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Chapter 1 
 
 
 
General Introduction 
1.1 Photochromism 
Photochromism is defined as the reversible conversion of a compound between two states A 
and B by irradiation with light.1 A photochromic system can be converted by irradiation with 
light (h*1) from state A to state B. The reverse reaction from B to A can be induced by 
irradiation with light of a different wavelength (h*2). The two photoisomers have different 
chemical and physical properties like different absorption wavelengths resulting in different 
colours. Figure 1 shows the UV-Vis absorption spectra of the conversion of a photochromic 
diarylethene derivative from state A to state B.  
 
Figure 1. UV-Vis absorption spectra of a photoisomerization reaction of a diarylethene with 
open state A and closed state B.  
1.2 Molecular Switches  
Molecular switches are photochromic compounds that can be toggled between two different 
isomers by an external stimuli like light, heat or electrons.2 Reversibly photoswitchable 
compounds are interesting for applications in optoelectronic data storage, as active parts of 
organic polymers with switchable refractive indices or as photochromic moieties used to 
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control biological processes.3,4 There are different classes of reversibly photswitchable 
compounds known like the azobenzenes,5 spiropyrans,6 dihydropyrans,7 fulgides and 
diarylethenes (Scheme 1).2, 3, 8 
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Scheme 1. Different examples of photo switches. A) Azobenzenes; B) Dihydropyrans; C) 
Diarylethenes; D) Fulgides. 
Many of this photoswitches find applications in different fields and areas, but the use of some 
of these compounds is limited by their chemical resistance, thermal stability and difficulties 
during synthesis of functionalized derivatives.2 
1.3 Diarylethenes  
1.3.1 Photo Characteristics  
One promising class of molecular switches are the diarylethenes because they exhibit high 
stability in both isomers, high photostationary states, high quantum yields and many of them 
have a high fatigue resistance.3  
1.3.2 Stilbene 
The simplest sample of a diarylethene is stilbene 6 (Scheme 2).3 The ring open isomer 6 can 
rotate around the sigma bonds which are connecting the central double bound with the 
phenyl-groups making it flexible. According to the Woodward-Hoffmann-rules,9 UV-irradiation 
induces a conrotatory 6-∏-electrocyclic reaction generating the conjugated 
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dihydrophenanthrene 7. The closed isomer is more rigid than the open isomer and almost 
planar to the conjugated ∏-system.3  
 
Scheme 2. Isomerization of stilbene and oxidation of dihydrophenanthrene. 
Beside the 6-∏-cyclization reaction, cis-stilbene undergoes an UV induced cis/trans 
isomerization reaction to trans-stilbene. Moreover, the closed isomer 7 is thermally not stable 
and reisomerizes immediately back to the open isomer at room temperature. Furthermore 
dihydrophenanthrene 7 can easily be oxidized to phenanthrene by oxygen or the oxidation 
may even occour spontaneously.3  
1.3.3 Dithienylethenes 
One popular class of diarylethenes are the dithienylethenes which exhibit a configuration that 
provides them promising photochromic properties (Figure 2).  
 
Figure 1. Configuration of a typical used dithienylethene. 
The central ring stabilizes the cis-conformation and prevents the cis/trans isomerization 
reaction. In many cases thiophenes are used as aryl unit because they have a small 
aromatic stabilization energy and this lead to thermally stable photochromic diarylethenes.2  
Table 1. Aromatic stabilization energy of different aryl groups.1  
Aryl group EAr [kJ/Mol] 
Phenyl 115.9 
Pyrrolyl 57.8 
Furyl 38.1 
Thienyl 19.7 
The 2-position of the thiophenes is mostly substituted with methyl groups to prevent the 
oxidation of the closed isomer. Substitution of the 5-position with different substituents offers 
General Introduction  
10 
the possibility to adjust the absorption wavelength of the conjugated ∏-system and to insert 
different anchor groups.  
1.3.4 Diarylethenes in this Thesis  
Diarylethenes are promising photochromic compounds and exhibit advanced photochemical 
properties. To get a better accessibility to this compound class and in order enlarge the 
scope of synthetic routes, a main part of this thesis is focused on the development of new 
synthetic routes. Chapter 2 and 3 deal with cycloaddition routes to the synthesis of reversibly 
photoswitchable diarylethenes. Chapter 5 of this thesis demonstrates the use of 
diarylethenes for biological applications and a diarylethene unit was used to synthesize a 
photoswitchable ligand with potential effect on the activation of the GABAA-receptor. Such a 
ligand could be a helpful tool to explore the functions of this ionic channel more detailed.  
1.4 References  
1. Altenhöner, K. Dissertation, University of Bielefeld: Germany, 2010.  
2. Vomasta, D. Dissertation; University of Regensburg: Germany, 2009. 
3. Irie, M. Chem. Rev. 2000, 100, 1685. 
4. Vomasta, D.; Branda, N.; König, B. Angew. Chem. Int. Ed. 2008, 47, 7644. 
5. Beharry, A. A.; Sadovsik, O.; Woolley, G. A. J. Am. Chem. Soc. 2011, 133, 19684. 
6. Brieke, C.; Heckel, A. Chem. Eur. J. 2013, 19, 15726. 
7. Pei, C. K.; Jiang, Y.; Shi, M. Org. Biomol. Chem. 2012, 10, 4355 
8. Thomas, C. J.; Wolak, M. A.; Birge, R. R.; Lees, W. J. J. Org. Chem. 2001, 66, 1914. 
9. Woodward, R. B.; Hofmann, R., The Conservation of Orbital Symmetrie, New York, 
 1970. 
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Chapter 2 
 
 
 
Synthesis and Photoisomerization of Diarylcyclobutenes 
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Symmetrically and unsymmetrically substituted diarylcyclobutenes are synthesized in 20 – 70 
% yield from alkyne precursors via cobalt-catalyzed [2+2] cycloadditions. The reactions 
proceed under mild conditions and provide access to differently substituted diarylethene 
derivatives. All the diarylcyclobutene products undergo reversible photoisomerization upon 
irradiation with UV/Vis light. The ring-closed isomers show different thermal stabilities 
towards reisomerization with half-lives ranging from 9 to 300 hours. 
 
The results described in this chapter are published: 
 
Raster, P.; Weiß, S.; Hilt, G.; König, B. Synthesis 2011, 905. 
 
Stefan Weiss synthesized norbornene derivative 6.  
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2.1 Introduction 
Reversibly photoswitchable compounds are interesting for applications in optoelectronic data 
storage, as active parts of organic polymers with switchable refractive indices,1 or as 
photochromic moieties used to control biological processes.2 One recent example is a 
diarylethene based photoswitchable inhibitor for the enzyme human carboanhydrase.3 With 
some diarylethenes both isomers show high fatigue resistance and good thermal stability, 
which is important for a variety of applications. However, the synthesis of derivatives of 
higher complexity is challenging, as known routes are either not versatile enough, or do not 
tolerate certain functional groups.4 The most convenient routes for diarylethene synthesis 
were reported by Feringa and Irie.5,6 The key step in the Feringa route is a McMurry coupling 
reaction using the corresponding diarylketone precursors to afford a five-membered ring 
system.7 The Irie route uses octaflourocyclopentene as the starting material, which is 
substituted with the appropriate lithiated aryl compounds giving fluorinated cyclopentenes.8 
Our goal was to establish a new route for the synthesis of symmetrically and unsymmetrically 
substituted diarylethenes. The described approach uses diarylalkynes, obtained via 
Sonogashira coupling, and a cobalt-catalyzed [2+2]-cycloaddition reaction to give the 
photochromic diarylethenes. This reaction sequence leads to diarylethenes bearing a 
cyclobutene moiety,9-16 a group of compounds not widely studied so far and allows the simple 
preparation of symmetrically and unsymetrically substituted derivatives. The photochromic 
properties of the new compounds were investigated.  
2.2 Results and Discussion 
2.2.1 Synthesis  
Symmetrically and unsymmetrically substituted diarylethenes 7a–c, 9a and 9b, with a central 
cyclobutene moiety, were prepared as shown in Scheme 1. Thiophene derivatives 1a-c were 
converted into iodoarenes 2a-c by bromine–iodine exchange using n-butyllithium and iodine 
(for 1a), or aromatic substitution with iodine and iodic acid (for 1b and 1c). Both reactions 
yielded the desired products in about 70 % yield. Palladium-catalyzed Sonogashira coupling 
of compounds 2 with ethynyltrimethylsilane, followed by cleavage of the trimethylsilyl 
protecting group with potassium carbonate gave alkynes 3 in good yields. Using a second 
Sonogashira cross-coupling reaction, terminal alkynes 3 were reacted with thiophenes 4 to 
yield diarylalkynes 5 as precursors for the subsequent cobalt-catalyzed [2+2] cycloaddition. 
This reaction was carried out under very mild conditions using the cobalt catalyst previously 
reported by Hilt.17-19 At room temperature, zinc was used as the reducing agent to generate 
the active catalytic cobalt(I) species. Maleimide derivative 6 and cyclopentene 8 were used 
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as the alkene components in the cycloaddition reaction. The yield of the reaction strongly 
depends on the nature of the diarylalkyne and its aryl substitution pattern. 
 
Scheme 1. i) n-BuLi, Et2O, I2; ii) I2, HIO3, H2O, AcOH, CCl4; iii) Me3SiC≡CH, 
Pd(PPh3)2Cl2,Ph3P, CuI, Et3N, THF; iv) K2CO3, MeOH; v) Pd(PPh3)2Cl2, Ph3P, CuI, Et3N, 
THF; vi) Co(dppp)Br2, ZnI2, Zn, CH2Cl2. 
Cycloaddition reactions of alkenes 6 and 8 with diarylalkynes 5a and 5b gave the 
corresponding products 7a, 7b, 9a and 9b in yields of 65-70 %, while benzothienyl 
substituted diarylalkynes 5c and 5d each reacted sluggishly, and only product 7c was 
isolated in a poor 20 % yield. 
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2.2.2 Photoisomerization and Photobleaching of 7a-c, 9a and 9b  
All the synthesized diarylethenes underwent reversible photochromic ring-closing reactions in 
dichloromethane on irradiation with UV light (320 nm), and ring-opening in the presence of 
visible light. The absorption properties and thermal stabilities of the ring-closed forms of 
compounds 7a–c, 9a and 9b are summarized in Table 1. 
Table 1. Photophysical Data of Compounds 7a–c, 9a and 9b. 
The ring-closed diarylethenes 7 and 9 can switch back to the ring-open isomers in the 
presence of visible light, and undergo a slow thermal cycloreversion reaction in the dark. The 
thermal ring-opening of related four membered ring systems has been described in the 
literature.9 The half-lives of the ring-closed isomers depend on the aromatic stabilization 
energies gained upon conversion into the ring-open isomer, and therefore on the thiophene 
substitution pattern.20 The thermal stabilities range from t1/2 = 8.9 h for compound 7a to t1/2 = 
300 h for the unsymmetrically substituted derivative 7b. The photoisomerization reactions 
were performed several times and a loss of about 50 % of the initial absorption intensity due 
to photodecomposition was observed after 10 irradiation cycles. Figure 1 (left) shows the 
changes in the absorption intensity of compound 7a, at 312 nm, over 10 photoisomerization 
cycles. 
 
Figure 1. Left: Photoisomerization and bleaching of compound 7a as monitored by changes 
in the absorption at 520 nm. Right: ORTEP representation of the X-ray crystal structure of 
compound 7a.  
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 1 2 3 4 5 6 7 8 9
A
b
s
o
r
p
t
i
o
n
Photo Cycles
entry 
λmax(nm) (ϵ 104) 
(open form) 
λmax(nm) 
(closed form) Thermal stability at r.t. [t1/2 (h)] 
7a 287 (3.3) 534 8.9 
7b 288 (1.5) 495 301.3 
7c 265 (4.1) 490 133.0 
9a 287 (4.1) 534 8.9 
9b 288 (3.3) 495 300.1 
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The structure of compound 7a was determined by X-ray crystal structure analysis (Figure 1, 
right). The conjugated thiophene rings are twisted due to steric interactions between the 
methyl substituents. The cyclobutene ring of the [2.2.1]bicycloheptene unit is exo configured, 
while the imide group adopts an endo orientation.  
2.3 Conclusion 
In summary, photoisomerizable diarylcyclobutenes were obtained from diarylalkynes via a 
cobalt-catalyzed [2+2] cycloaddition reaction. The efficiency of the ringclosing reaction 
depends on the structure of the diarylalkyne precursor, and product yields of up to 70 % were 
obtained. The products undergo reversible photochromic reactions in dichloromethane by 
alternating irradiation with UV-light and visible light. A specific advantage of the presented 
synthetic route is the simpler access to diarylethenes bearing two different aryl substituents. 
2.4 Experimental  
2.4.1 General Experimental Conditions 
The following compounds were prepared according to literature methods: 3-bromo-2-methyl-
5-phenylthiophene (1a),21 2-methyl- benzo[b]thiophene (1c),22 3-iodo-2-methyl-5-
phenylthiophene (2a),20 3-iodo-2-methylbenzo[b]thiophene (2c)21 and 1,2-bis(2- methyl-5-
phenylthiophene-3-yl)ethyne (5a).22 All other  reagents were obtained from commercial 
sources. Unless otherwise noted, solvents (analytical grade) were purchased from 
commercial suppliers and used without further purification. Melting points were obtained 
using a Lambda Photometrics Optimelt MPA100 apparatus (Lambda Photometrics, 
Harpenden, UK), and are not corrected. IR spectra were obtained using a Varian Biorad FT-
IR Excalibur FTS 3000 spectrometer. 1H NMR spectra were recorded at 300 MHz on a 
Bruker Avance 300 spectrometer, or at 600 MHz on a  Bruker Avance III Br600 with a 
cryogenic probe head (Bruker, Karlsruhe, Germany). 13C NMR spectra were recorded at 75 
MHz on a Bruker Avance 300 spectrometer. The NMR spectra were recorded in CDCl3 as 
solvent and chemical shifts are reported in ppm. UV/Vis spectra were recorded using a 
Varian Cary BIO 50 UV/Vis/NIR spectrophotometer (Varian Inc., CA, USA). Mass spectra 
were obtained using Finnigan SSQ 710A (EI), Finnigan MAT 95 (CI) or Finnigan MAT TSQ 
7000 (Thermo  FINNIGAN, USA) (ES/LC–MS) instrumentation. Thin layer chromatography 
(TLC) was performed on alumina plates coated with silica gel (Merck silica gel 60 F245, 
thickness 0.2 mm). Column chromatography was accomplished with Merck Geduran SI 60 
silica gel as the stationary phase. Petroleum ether (PE) refers to the fraction boiling at 30–60 
°C. 
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2.4.2 Synthetic Protocols and Analytical Data of 3c, 5b-d, 7a-c, 9a and 9b  
3-Ethynyl-2-methylbenzo[b]thiophene (3c) 
A mixture of THF–Et3N (48 mL, 2:1) was degassed for 10 min and then 3-iodo-2-
methylbenzo[b]thiophene 2c (5.3  g, 19.3 mmol), TMS-acetylene (5.57 mL, 38.7 mmol),  
Pd(PPh3)2Cl2 (54  mg, 0.4 mol%), Ph3P (40 mg, 0.8 mol%) and CuI (29 mg, 0.6 mol%) were 
added under nitrogen. The resulting solution was heated at 65 °C for 12 h. The reaction 
mixture was cooled, Et2O (40 mL) and H2O (40 mL) were added and the organic layer was 
separated. Subsequently, the water layer was extracted with Et2O (2 × 40 mL). Then the 
organic layers were combined, dried over MgSO4 and the solvent was removed. The residue 
was dissolved in MeOH (220 mL), K2CO3 (2.97 g, 21.1 mmol) was added and the resulting 
solution was stirred for 2 h at r.t. The reaction mixture was filtered, the solvent was removed 
and the residue was purified by silica gel flash chromatography (PE; Rf = 0.6) and a white 
solid was obtained (70 %), mp 174-176 °C. 1H NMR (300 MHz, CDCl3): δ = 2.72 (s, 3H), 3.48 
(s, 1H), 7.30-7.41 (m, 2H), 7.77 (d, J = 8.0 Hz, 1H), 7.86 (d, J = 8.0 Hz, 1H) ppm; 13C NMR 
(75 MHz, CDCl3): δ = 15.4, 82.3, 111.5, 114.8, 122.0, 122.4, 124.5, 124.7, 137.4, 140.0, 
146.6 ppm; IR (film): ʋ = 2952, 2854, 1458, 1377, 1122, 933, 815 cm-1; HRMS (EI): 
calculated for C11H8S 172.0347; found 172.0342. 
 
Diarylalkynes 5b-d; General Procedure (GP 1) 
A mixture of THF–Et3N (24 mL, 2:1) was degassed for 10 min and then iodothiophene 4a–c 
(10.0 mmol), acetylene 3a–c (10.0 mmol), Pd(PPh3)2Cl2 (27 mg, 0.4 mol%), Ph3P (20 mg, 0.8 
mol%) and CuI (15 mg, 0.6 mol%) were added under nitrogen. The resulting solution was 
heated at 65 °C for 12 hours. The reaction mixture was cooled, Et2O (20 mL) and H2O (20 
mL) were added and the organic layer was separated. Subsequently, the water layer was 
extracted with Et2O (2 × 20 mL) and then the organic layers were combined and dried over 
MgSO4. The solvent was removed and the residue was purified by silica gel flash 
chromatography (PE/EE, 9.5:0.5 v/v). 
 
3-((2,5-Dimethylthiophen-3-yl)ethynyl)-2-methyl-5-phenylthiophene (5b) 
The compound was prepared according to GP 1 yielding 75 % of 5b as a white solid, mp 
161-163 °C. 1H NMR (300 MHz, CDCl3): δ = 2.41 (s, 3H), 2.52 (s, 3H), 2.58 (s, 3H), 6.68 (s, 
1H), 7.22 (s, 1H), 7.24-7.30 (m, 2H), 7.34-7.40 (m, 2H), 7.52-7.57 (m, 1H) ppm; 13C NMR (75 
MHz, CDCl3): δ = 14.5, 14.7, 15.2, 85.6, 86.7, 119.4, 121.1, 125.2, 125.6, 127.1, 127.5, 
128.9, 134.0, 135.9, 140.2, 140.9, 142.2 ppm; IR (film): ν  = 2337, 1605, 1301, 748, 539, 
496 cm-1; HRMS (EI): calculated for C19H16S2 308.0693; found 308.0690. 
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2-Methyl-(3-((2-methyl-5-phenylthiophen-3-yl)ethynyl)benzo[b]thiophene (5c) 
The compound was prepared according to GP 1 yielding 75 % of 5c as a brown solid, mp 
168-170 °C. 1H NMR (300 MHz, CDCl3): δ = 2.64 (s, 3H), 2.71 (s, 3H), 7.23-7.42 (m, 5H), 
7.54-7.58 (m, 2H), 7.73 (d, J = 7.7 Hz, 1H), 7.86 (d, J = 7.4 Hz, 2H) ppm; 13C NMR (75 MHz, 
CDCl3): δ = 14.8, 15.4, 84.8, 89.1, 116.0, 120.9, 122.1, 122.4, 124.5, 124.7, 125.2, 125.6, 
127.6, 129.0, 133.9, 137.5, 139.9, 140.4, 142.6, 144.4 ppm; IR (film): ν = 2911, 2336, 2197, 
1595, 837, 681 cm-1; HRMS (EI): calculated for C22H16S2 344.0693; found 344.0695.  
 
1,2-Bis(2-methylbenzo[b]thiophen-3-yl)ethyne (5d) 
The compound was prepared according to GP 1 yielding 50 % of 5d as a yellow solid, mp 
155-157 °C. 1H NMR (300 MHz, CDCl3): δ = 2.77 (s, 6H), 7.30-7.48 (m, 4H), 7.75 (d, J = 7.9 
Hz, 2H), 7.93 (d, J = 7.6 Hz, 2H) ppm; 13C NMR (75 MHz, CDCl3): δ = 15.5, 87.7, 116.0, 
122.1, 122.4, 124.5, 124.8, 137.6, 139.8, 144.5 ppm; IR (film): ν  = 3053, 2360, 1740, 720, 
620, 557 cm-1; HRMS (EI): calculated for C20H14S2 318.0537; found 318.0539. 
 
Diarylcyclobutenes 7a-c; General Procedure (GP 2) 
In a Schlenk tube, [1,3-bis(diphenylphosphino)propante]cobalt(II)bromide [Co(dppp)Br2] (64 
mg, 0.1 mmol, 20 mol%), anhydrous ZnI2 (64 mg, 0.2 mmol, 40 mol%) and Zn powder (13 
mg, 0.2 mmol, 40 mol%) were dissolved in anhydrous DCM (2 mL) under nitrogen. The 
alkyne 5a-c (0.5 mmol) and alkene 6 (0.5 mmol) were added and the mixture was stirred for 
24 h at r.t. DCM (10 mL) and H2O (10 mL) were then added to the reaction mixture and the 
organic layer was separated. Subsequently, the water layer was extracted with DCM (2 x 10 
mL) and then the organic layers were combined and dried over MgSO4. The solvent was 
removed and the residue was purified by silica gel flash chromatography.   
 
2-Methyl-5,6-bis(2-methyl-5-phenylthiophen-3-yl)-3a,4,4a,6a,7,7a-hexahydro-1H-4,7-
methanocyclobuta[f]isoindole-1,3(2H)-dione (7a)  
The compound was prepared according to GP 2 yielding 70 % of 7a as a purple solid after 
purification by column chromatography on silica gel (PE/EE, 1:1 v/v), mp 223-225 °C. 1H 
NMR (300 MHz, CDCl3): δ = 1.50 (d, J = 10.7 Hz, 1H), 2.11 (d, J = 10.7 Hz, 1H), 2.27 (s, 6H), 
2.80-2.85 (m, 2H), 2.96 (s, 2H), 3.01 (s, 3H), 3.27-3.30 (m, 2H), 7.09 (s, 2H), 7.20-7.28 (m, 
2H), 7.30-7.38 (m, 4H), 7.48-7.53 (m, 4H) ppm; 13C NMR (75 MHz, CDCl3): δ = 14.9, 24.4, 
34.7, 37.5, 44.0, 48.1, 122.8, 125.4, 127.4, 128.9, 133.7, 134.0, 134.2, 136.7, 140.4, 177.8 
ppm; IR (film): ν  = 2353, 2132, 1533, 1442, 1291, 1030, 883, 773, 631, 537, 498 cm-1; 
HRMS (EI): calculated for C34H29NO2S2 547.1640; found 547.1648. 
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5-(2,5-Dimethylthiophen-3-yl)-2-methyl-6-(2-methyl-5-phenylthiophen-3-yl)-
3a,4,4a,6a,7,7a-hexahydro-1H-4,7-methanocyclobuta[f]isoindole-1,3(2H)-dione (7b) 
The compound was prepared according to GP 2 yielding 65 % of 7b as purple oil after 
purification by column chromatography on silica gel (PE/EE, 1:1 v/v). 1H NMR (300 MHz, 
CDCl3): δ = 1.42 (d, J = 10.6 Hz, 1H), 2.02 (d, J = 10.6 Hz, 1H), 2.12 (s, 3H), 2.21 (s, 3H), 
2.32 (s, 3H), 2.74 (s, 2H), 2.82-2.90 (m, 2H), 2.94 (s, 3H), 3.22-3.30 (m, 2H), 6.50 (s, 1H), 
7.01 (s, 1H), 7.16-7.20 (m, 1H), 7.25-7.30 (m, 2H), 7.43-7.47 (m, 2H) ppm; 13C NMR (75 
MHz, CDCl3): δ 14.6, 14.8, 15.1, 24.4, 34.6, 37.5, 43.9, 48.2, 77.3, 122.9, 125.1, 125.4, 
127.3, 128.9, 132.5, 133.3, 133.9, 134.1, 134.7, 134.9, 136.0, 136.5, 140.2, 177.8 ppm; IR 
(film): ν  = 2927, 2361, 2253, 2168, 1769, 1695, 1598, 1434, 1136, 997, 631 cm-1; HRMS 
(EI): calculated for C29H27NO2S2 485.1483; found 485.1489.  
 
2-Methyl-5-(2-methyl-5-phenylthiophe-3-yl)-6-(2-methylbenzo[b]thiophen-3-yl)-
3a,4,4a,6a,7,7a-hexahydro-1H-4,7-methanocyclobuta[f]isoindole-1,3(2H)-dione (7c) 
The compound was prepared according to GP 2 yielding 20 % of 7c as purple oil after 
purification by preparative HPLC. 1H NMR (300 MHz, CDCl3): δ = 1.28 (d, J = 10.7 Hz, 1H), 
1.54 (d, J = 10.7 Hz, 1H), 2.10 (s, 3H), 2.42 (s, 3H), 2.66 (d, J = 5.3 Hz, 1H), 3.01 (d, J = 5.4 
Hz, 1H), 3.03-3.05 (m, 4H), 3.20-3.21 (m, 1H), 3.25 (dd, J = 5.4, 9.2 Hz, 1H), 3.34 (dd, J = 
5.4, 9.2 Hz, 1H), 6.99 (s, 1H), 7.21-7.32 (m, 5H), 7.39-7.40 (m, 2H), 7.51-7.56 (m, 1H), 7.73-
7.76 (m, 1H) ppm; 13C NMR (75 MHz, CDCl3): δ = 14.7, 15.5, 24.4, 34.9, 37.3, 37.8, 43.8, 
45.3, 47.9, 48.3, 122.0, 122.4, 123.8, 124.3, 125.4, 127.3, 128.0, 128.8, 132.6, 133.6, 133.9, 
137.1, 137.8, 137.9, 138.8, 139.3, 140.3, 177.6, 177.8 ppm; IR (film): ν  = 3061, 2933, 2360, 
2169, 1942, 1697, 1596, 1433, 1229, 1032, 831, 686, 420 cm-1; HRMS (EI): calculated for 
C32H27NO2S2 521.1483; found 521.1490.  
 
Diarylcyclobutenes 9a and 9b; General Procedure (GP 3) 
In a Schlenk tube, [1,3-bis(diphenylphosphino)propane]cobalt(II)bromide [Co(dppp)Br2] (64 
mg, 0.1 mmol, 20 mol%), anhydrous ZnI2 (64 mg, 0.2 mmol, 40 mol%) and Zn powder (13 
mg, 0.2 mmol, 40 mol%) were dissolved in anhydrous DCM (2 mL) under nitrogen. The 
alkyne 5a or 5b (0.5 mmol) and cyclopentene 8 (0.045 ml, 0.5 mmol) were added and the 
mixture was stirred for 24 h at r.t. DCM (10 mL) and H2O (10 mL) were then added to the 
reaction mixture and the organic layer was separated. Subsequently, the water layer was 
extracted with DCM (2 x 10 mL) and then the organic layers were combined and dried over 
MgSO4. The solvent was removed and the residue was purified.  
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6,7-Bis(2-methyl-5-phenylthiophen-3-yl)bicyclo[3.2.0]hept-6-ene (9a) 
The compound was prepared according to GP 3 yielding 65 % of 9a as purple oil after 
purification by preparative HPLC. 1H NMR (300 MHz, CDCl3): δ = 1.35-1.47 (m, 2H), 1.74-
1.88 (m, 4H), 2.29 (s, 6H), 3.94 (d, J = 6.5 Hz, 2H), 7.18 (s, 2H), 7.21-7.26 (m, 2H), 7.32-7.37 
(m, 4H), 7.51-7.54 (m, 4H) ppm; 13C NMR (75 MHz, CDCl3): δ = 14.8, 23.4, 26.8, 46.9, 123.2, 
125.4, 127.1, 128.8, 134.3, 134.9, 135.6, 135.8, 139.9 ppm; IR (film): ν  = 2361, 2170, 1740,  
The compound was prepared according to GP 3 yielding 65 % of 9b as a orange oil after 
purification by column chromatography on silica gel (PE/EE, 9.75:0.25 v/v). 1H NMR (300 
MHz, CDCl3): δ = 1.30-1.42 (m, 2H), 1.68-1.84 (m, 4H), 2.20 (s, 3H), 2.26 (s, 3H), 2.38 (s, 
3H), 3.40-3.47 (m, 2H), 6.59 (s, 1H), 7.13 (s, 1H), 7.20-7.37 (m, 3H), 7.49-7.53 (m, 2H) ppm; 
13C NMR (75 MHz, CDCl3): δ = 14.5, 14.7, 15.2, 23.3, 26.8, 30.3, 46.8, 77.0, 123.3, 125.3, 
125.4, 127.1, 128.8, 133.6, 133.9, 134.4, 134.8, 135.3, 135.5, 135.7, 136.0, 139.7 ppm; IR 
(film): ν  = 2360, 2339, 2207, 2171, 2116, 2032, 1740, 1669, 1437, 1374, 1220, 834 cm-1; 
HRMS (EI): calculated for C29H26S2 376.1327; found 367.1319.  
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Chapter 3 
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Functionalized photoswitches in two steps – Photochromic dithienylcyclohexenes were 
prepared by a cobalt-mediated Diels-Alder reaction of internal alkynes with isoprenyl-
pinacolboronic ester. The primary cycloaddition products were reacted in situ with different 
aldehydes introducing an additional functional group, which allows immobilization on 
cellulose or silica gel. The three-component one-pot reaction sequence provides the 
photochromic dithienylcyclohexenes in up to 67 % overall yield.  
 
The results described in this chapter are published: 
 
Raster, P.; Schmidt, A.; Rambow, M.; Kuzmanovic, N.; König, B.; Hilt, G. Chem. Commun. 
2014, accepted.  
 
Natascha Kuzmanovic prepared the internal alkynes 1b-d. Maxie Rambow synthesized 
diarycyclohexenes 5a and 5c by cobalt mediated Diels-Alder and allylboration reactions. 
Diarylcyclohexenes 5b and 5d-g were synthesized by Anastasia Schmidt.   
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3.1 Introduction 
Photochromic compounds find increasing interest in material science1-3 or as tools in 
molecular biology.4-6 Recent applications are optical data storage,7-9 materials with 
photoswitchable refractive indices10-11 or conformation12-13 and photochromic agonists or 
inhibitors that affect the physiological activity of ionic channels,14 enzymes15-16 and proteins.17 
Widely used are photochromic diarylethenes, which show in many cases high fatigue 
resistance, complete photoisomerization and slow thermal interconversion of the 
photoisomers.18-19 However, the synthesis of diarylethenes, particular of unsymmetrically 
substituted compounds is laborious. Two main routes for the synthesis of diarylethenes were 
reported by Irie20 and Feringa.21 The Irie route uses volatile octafluorocyclopentene as 
starting material, which is reacted with the corresponding lithiated arenes. The Feringa route 
starts from a diarylketone precursor, which is ring-closed by a McMurry coupling reaction.22 
However, the synthesis does not tolerate certain functional groups like aldehydes and 
ketones. Therefore we explored cycloaddition routes23-25 for the synthesis of photochromic 
diarylethenes and reported recently the cobalt catalyzed [2+2] cycloaddition reaction of 
diarylalkynes with cyclopentene or norbornene derivatives.26 The method yields 
dithienylcyclobutenes, but their fatigue resistance is unfortunately low. Searching for more 
photostable cycloaddition products we investigated the cobalt-mediated Diels-Alder 
cycloaddition of dithienylacetylenes 1a-d with boroprene 2 [= isoprenylpinacolboronic ester 2 
(Pin = pinacole)]27 giving the dihydroaromatic intermediates 3a-d (Table 1). The allylboronic 
ester reacts in situ with aldehydes 4a-d affording photochromic diarylcyclohexenes 5a-g. 
This last step of the synthesis allows the facile introduction of a variety of moieties or 
functional groups modifying the backbone of the photoswitch without altering its 
photophysical properties. The modification can be used to introduce specific labels, probes, 
binding sites or anchoring groups for immobilization. For the Diels-Alder-type [4+2] 
cycloaddition, an established catalyst system consisting of Co(dppe)Br2, zinc iodide and zinc 
powder in dichloromethane was used.28 
3.2 Results and Discussion 
3.2.1 Synthesis  
The catalyst converts a range of dithienylalkynes 1a-d and boroprene 2 under mild reaction 
conditions into the dihydroaromatic dithienylethenes 3a-d. The products of the cycloaddition 
reaction are subsequently reacted without isolation with different aldehydes 4a-d yielding the 
desired diarylcyclohexenes 5a-g in moderate to good overall yield. The results of this three-
component one-pot reaction sequence are summarized in Table 1. 
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Table 1. Synthesis of functionalized dithienylethenes 5a-g by [4+2] cycloaddtion. 
 
entry Alkyne R1 R2 R3 R4 Aldehyde R5 Yield 
1 1a H Ph H Ph 4a 
 
5a (64%) 
2 1a H Ph H Ph 4b 
 
5b (29%) 
3 1a H Ph H Ph 4c 
 
5c (58%) 
4 1a H Ph H Ph 4d 5d (67%) 
5 1b H Cl H Cl 4a 
 
5e (32 %) 
6 1c 
 
H Ph 4a 
 
5f (5 %)a 
7 1d H Me H Ph 4c 
 
5g (30 %)b 
(a) The product could not be isolated and the yield determined by LC-MS was 5 %. (b) 
Compound 5g was obtained as regioisomeric mixture A : B = 59 : 41 %. 
3.2.2 Photoisomerization and Photobleaching of 5a-e and 5g 
Compounds 5a-e and 5g photoisomerize reversibly in solution upon irradiation with light of 
312 nm wavelength. This is exemplarily shown for compound 5d in Figure 1 (left). The closed 
isomers are stable for days in the dark and isomerize quantitatively to the open forms upon 
irradiation with a 200 W tungsten light source that was passed through a 420 nm cut-off filter 
to eliminate shorter wavelengths. Diarylethenes 5a-e and 5g photodegrade in solution. After 
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no dye could be detected in the rinsing solution. After drying, the cellulose sheet 7 showed 
visible photochromic properties upon irradiation with UV-light and visible light for several 
cycles (Figure 2).  
 
Figure 2. A photochromic cellulose sheet. Irradiation with low intensity UV-light (312 nm) 
converts the sheet from A to B; day light irradiation converts it back from B to A. 
The average dye loading of the cellulose sheet was determined gravimetrically to be 
3.0 ± 0.8·10-4 mmoldye/mgcellulose. This corresponds to about 5 % conversion of the cellulose 
primary hydroxyl groups. Dithienlyethene 5d bearing a phosphonate ester was used to 
prepare a photochromic pigment on SiO2. Silica gel powder (0.04−0.063 mm) was incubated 
with a solution of diarylcyclohexene 5d in dichloromethane for 12 h. The reaction mixture 
was filtered and washed with dichloromethane and ethanol until no coloration of the rinsing 
solvent was detected after irradiation with UV-light. The dye loading of the SiO2 was 
determined by elemental analysis to be 2.2·10-5 mmoldye/mgsilicagel. The functionalized SiO2 
powder is reversible photochromic and showed a broad absorption at 522 nm after UV-
irradiation (Figure 3). Suspending the coated silica gel in water with poly-2-ethyloxazoline 
polymer (200.000 g/mol) gave a photochromic paint. Unfortunately, the immobilized 
chromophores bleach more quickly than in solution and after three photocycles the relative 
absorption of the closed isomer decreased to less than 50 %. The immobilization of 
compound 5d on TiO2 (P-25) semiconductor using the same protocol gave particles that did 
not show photochromic behaviour upon irradiation with UV-light. 
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Figure 3. Solid state UV-spectra changes of SiO2 with immobilized compound 5d upon 
irradiation with UV-light of 312 nm and visible light. Dashed line: Spectrum before UV- 
irradiation. Solid line: Spectrum after 30 s UV-irradiation.  
3.3 Conclusion  
In conclusion, we have developed a new cycloaddition route for the synthesis of reversible 
photochromic dithienylcyclohexenes in a three-component one-pot reaction. The 
chromophores were generated via a cobalt-mediated Diels-Alder reaction of internal 
dithienylalkynes with isoprenylpinacolboronic ester under mild reaction conditions followed by 
an allylboration with various aldehydes. The aldehydes allow the facile introduction of 
different functional groups without affecting the chromophore. Applications of the 
functionalized dithienylethenes were demonstrated by immobilizing the chromophore onto 
cellulose and silica gel powder retaining their photochromic properties. The reported reaction 
sequence facilitates the preparation of functionalized photochromic dithienylethenes and may 
thereby increase their availability for photonic applications. 
3.4 Experimental  
3.4.1 General Experimental Conditions 
The following compounds were prepared according to literature methods: 1,2-bis(2-methyl-5-
phenylthiophene-3-yl)ethyne (1a),26 2-methyl-3-((2-methyl-5-phenylthiophen-3-yl)ethynyl)-
benzo[b]thiophene (1c),26 3-((2,5-dimethylthiophen-3-yl)ethynyl)-2-methyl-5-phenylthiophene 
(1d),26 4,4,5,5-tetramethyl-2-(2-methylenebut-3-en-1-yl)-1,3,2-dioxaborolane (2).27 All other  
reagents were obtained from commercial sources. IR spectra were obtained using an IFS 
200 Interferometer or an Alpha-P FT-IR-spectrometer both manufactured by Bruker Physics. 
1H NMR spectra were recorded either on an AV-300  (300 MHz) or DRX-500 (500 MHz) both 
manufactured by Bruker  Physics. 13C NMR spectra were recorded on either an AV-300 (75 
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MHz or an DRX-500 (150 MHz) both manufactured by Bruker Physics. The NMR spectra 
were recorded in CDCl3 or MeOD as solvent and chemical shifts are reported in ppm. GC/MS 
spectra were recorded utilizing an Agilent 6890 GC-System coupled with a Hewlett Packard 
5973 Mass Selective Detector. Ionization was accomplished by electron ionization (EI) at an 
energy of 70 eV. The detected ion masses (m/z) are reported in u corresponding to the 
intensity of the  signals  as  a  percentage  of  the most intense signal. High-resolution mass 
spectra (HRMS) were  recorded as electron ionization spectra (EI/HRMS) at an energy of 
70 eV on a Finnigan MAT  95S Mass Spectrometer or as electron spray ionization 
(ESI/HRMS) on a Micromass VG AutoSpec Mass Spectrometer. The detected ion masses 
(m/z) are given in u. Thin layer chromatography (TLC) was carried out on prefabricated 
plates (silica gel 60, F254 with fluorescence indicator) manufactured by Merck. Flash 
chromatography (FC) was carried out on silica gel 60 (40 – 64 µm, 230 – 400  mesh  ASTM)  
purchased  from Macherey-Nagel. Petroleum ether (PE) refers to the fraction boiling at 30-60 
°C. 
3.4.2 Synthetic Protocols and Analytical Data of 1b, 4c and 5a-g  
1,2-Bis(5-chloro-2-methylthiophen-3-yl)ethyne (1b) 
A mixture of NEt3 (10 mL) and THF (20 mL) was degassed for 10 min and finally 5-chloro-3-
iodo-2-methylthiophene (2.97 g, 11.5 mmol), 5-chloro-3-ethynyl-2-methylthiophene (1.20 g, 
7.7 mmol), bis-triphenylphosphinpalladium(II)-chlorid (110 mg, 2 mol %), triphenylphosphine 
(80 mg, 4 mol %) and CuI (60 mg, 4 mol %) were added under nitrogen and the solution was 
refluxed for 24 h at 60 °C. The solution was allowed to warm up, the organic phase was 
separated, washed with water (2 x 50 ml) and dried over MgSO4. The solvent was 
evaporated and the precipitate was purified by silica gel chromatography (PE) and a white 
solid was obtained. Yield: (2.0 g, 64 %), mp 64-66 °C. 1H NMR (300 MHz, CDCl3): δ = 2.37 
(s, 6H), 6.80 (s, 2H) ppm; 13C NMR (75 MHz, CDCl3): δ = 14.5, 77.2, 115.1, 125.8, 127.9, 
141.8 ppm; HRMS (EI): calculated for C12H8Cl2S2 285.9445; found: 285.9443. 
 
Diethyl(4-formylphenyl)phosphonate (4c) 
A mixture of triethyl phosphite (1.35 g, 7.4 mmol), 4-bromobenzaldehyde (1.36 g, 7.4 mmol) 
and NiBr2 (35 mg, 0.16 mmol) was heated for 4 h at 170 °C. The reaction mixture was finally 
purified by flash column chromatography on silica gel (PE/EE, 9:1 v/v), followed by vacuo 
short path distillation. A colorless oil was obtained. Yield: (1.03 g, 33 %). Analytics is in good 
agreement to literature reported values.29 
 
Diarylcyclohexenes 5a-g; General Procedure (GP 1) 
Anhydrous zinc iodide (2.0 eq.), zinc powder (2.0 eq.) and Co(dppe)Br2 (1.0 eq.) were 
suspended in anhydrous dichloromethane (concentration of Co(dppe)Br2: 0.2 M) under an 
Immobilization of Photoswitchable Diarylcyclohexenes Synthesized via Cobalt-Mediated 
Diels-Alder Reaction 
28 
argon atmosphere in a flame dried Schlenk tube fitted with a teflon screwcap. The internal 
alkyne 1a-d (1.0 eq.) and 4,4,5,5-tetramethyl-2-(2-methylenebut-3-enyl)-1,3,2-dioxaborolane 
(= boroprene, 3.0-5.0 eq.) were added and the mixture was stirred at room temperature until 
complete conversion of the starting materials was indicated by TLC. The reaction mixture 
was cooled to 0 °C, the aldehyde 4a-d (4.0–10.0 eq.) was added and the mixture was stirred 
at 0 °C. The progress of the reaction was monitored by TLC. Triethanolamine (1.2 eq. based 
on the dioxoborolane) was added at room temperature. After stirring for 1 h the reaction 
mixture was adsorbed on a small amount of silica gel and purified by column 
chromatography to afford the desired compound.  
 
(E)-1-(3,4-Bis(2-methyl-5-phenylthiophen-3-yl)-6-methylencyclohex-3-en-1-yl)but-2-en-
1-ol (5a) 
The compound was prepared according to GP 1 yielding 64 % of 5a as brownish solid after 
purification by column chromatography on silica gel (Pentane/Et2O, 1:1 v/v). 1H NMR (300 
MHz, CDCl3): δ = 1.80 (dd, J = 1.5, 6.4 Hz, 3H), 1.85 (d, J = 2.0 Hz, 1H), 2.01 (s, 3H), 2.04 
(s, 3H), 2.53-2.69 m (2H), 3.14-3.33 (m, 2H), 4.29 (t, J = 8.9 Hz, 1H), 5.12 (d, J = 7.6 Hz, 
2H), 5.55 (ddd, J = 1.5, 8.3, 15.2 Hz, 1H), 5.84 (qd, J = 6.4, 12.9 Hz, 1H), 6.90 (s, 1H), 7.00 
(s, 1H), 7.20-7.24 (m, 2H), 7.30-7.35 (m, 4H), 7.43-7.49 (m, 4H) ppm; 13C NMR (75 MHz, 
CDCl3): δ = 14.3, 14.4, 17.9, 35.1, 37.3, 48.2, 72.9, 111.7, 124.1, 124.2, 125.3, 127.0, 128.8, 
129.8, 130.2, 132.3, 134.1, 134.1, 134.5, 139.4, 139.6, 139.8, 144.7 ppm; IR (KBr): ν  = 
3434, 3062, 3022, 2911, 2243, 1947, 1871, 1798, 1651, 1598, 1499, 1437, 1376, 1304, 
1200, 1159, 1116, 1076, 1004, 965, 902, 840, 754, 728, 689 cm-1; HRMS (EI): calculated for 
C33H32OS2: 508.1895; found: 589.1898. 
 
tert-Butyl (2-(3,4-bis(2-methyl-5-phenylthiophen-3-yl)-6-methylenecyclohex-3-en-1-yl)-
2-hydroxyehtyl)carbamate (5b) 
The compound was prepared according to GP 1 yielding 25 % of 5b as purple solid after 
purification by column chromatography on silica gel (Pentane/Et2O, 1:1 v/v). 1H NMR 
(500 MHz, CDCl3): δ = 1.47 (m, 9H), 2.02 (s, 6H), 2.46-2.84 (m, 4H), 3.11-3.33 (m, 3H), 3.62-
3.69 (m, 1H), 3.99 (t, J = 7.1 Hz, 1H), 5.02-5.11 (m, 2H), 5.12 (d, J = 0.9 Hz, 1H), 6.99 (s, 
1H), 7.17-7.25 (m, 3H), 7.28-7.36 (m, 4H), 7.44-7.58 (m, 4H) ppm; 13C NMR (126 MHz, 
CDCl3): δ = 14.5 (2H), 28.5, 35.2, 38.1, 44.7, 45.6, 71.0, 79.8, 111.8, 124.1, 124.8, 125.4 
(2C), 127.0 (2C), 128.9 (2C), 129.9, 130.4, 134.2, 134.5, 134.6 (2C), 139.5, 139.7 (2C), 
139.8, 144.6, 156.7 ppm; IR (film): ν = 3426, 3065, 2972, 2971, 2857, 1701, 1599, 1503, 
1442, 1397, 1367, 1251, 1166, 1094, 1033, 898, 846, 756, 692 cm-1; HRMS (EI): calculated 
for C36H39NO3S2 + Na+ 620.2264; found 620.2261. 
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(3,4-Bis(2-methyl-5-phenylthiophen-3-yl)-6-methylencyclohex-3-enyl)(3-nitrophenyl)-
methanol (5c) 
The compound was prepared according to GP 1 yielding 58 % of 5c as purple solid after 
purification by column chromatography on silica gel (Pentane/Et2O, 1:1 v/v). 1H NMR 
(300 MHz, CDCl3): δ = 2.02 (s, 3H), 2.09 (s, 3H), 2.53-2.62 (m, 2H), 2.79-2.85 (m, 1H), 3.23-
3.42 (m, 2H), 4.99 (d, J = 9.8 Hz, 1H), 5.25 (s, 2H), 6.83 (s, 1H), 7.04 (s, 1H), 7.19-7.24 (m, 
2H), 7.25-7.43 (m, 5H), 7.48-7.58 (m, 4H), 7.74 (d, J = 7.7 Hz, 1H), 8.19 (ddd, J = 1.0, 2.2, 
8.2 Hz, 1H), 8.32-8.34 (m, 1H) ppm; 13C NMR (75 MHz, CDCl3): δ = 14.4, 14.5, 34.8, 37.1, 
50.2, 73.3, 113.1, 122.3, 123.2, 123.6, 123.8, 125.2, 125.3, 127.1, 128.8, 129.2, 129.5, 
130.4, 133.3, 134.1, 134.2, 139.2, 139.3, 139.9, 143.8, 144.4, 148.4 ppm; IR (KBr): ν  = 
3533, 3064, 2912, 2248, 1947, 1646, 1597, 1527, 1499, 1470, 1437, 1346, 1199, 1147, 
1028, 971, 901, 841, 809, 756, 729, 687 cm-1; HRMS (EI): calculated for C36H31NO3S2 
589.1745; found: 589.1756. 
 
Diethyl(4-((3,4-bis(2-methyl-5-phenylthiophen-3-yl)-6-methylenecyclohex-3-en-1-yl)-
(hydroxyl)methyl)phenyl)phosphonate (5d) 
The compound was prepared according to GP 1 yielding 67 % of 5d as pink-coloured oil 
after purification by column chromatography on silica gel (EE). 1H NMR (500 MHz, CDCl3): δ 
= 1.29 (dt, J = 7.1, 2.0 Hz, 6H), 1.98 (s, 3H), 2.07 (s, 3H), 2.05-2.09 (m, 1H), 2.50-2.54 (m, 
1H), 2.56 (s, 1H), 2.81-2.85 (m, 1H), 3.24 (d, J = 19.9 Hz, 1H), 3.43 (d, J = 19.8 Hz, 1H), 
4.01-4.17 (m, 4H), 4.90 (d, J = 9.9 Hz, 1H), 5.21 (s, 2H), 6.79 (s, 1H), 7.02 (s, 1H), 7.19-7.24 
(m, 2H), 7.30 (d, J = 8.0 Hz, 2H), 7.33 (d, J = 7.7 Hz, 2H), 7.39 (d, J = 8.2, 1.0Hz, 2H), 7.48 
(d, J = 8.3 Hz, 2H), 7.53 (dd, J = 8.1, 3.9 Hz, 2H), 7.83 (dd, J = 13.1, 8.1 Hz, 2H) ppm; 13C 
NMR (125 Mhz, CDCl3): δ = 14.4, 14.5, 16.3 (2C), 34.9, 37.2, 50.0, 62.1, 62.2, 73.7, 112.5, 
123.9, 125.2, 125.3, 126.99, 127.0 (2C), 127.4, 128.8 (2C), 129.4, 130.2, 132.1, 134.0, 
134.30 (2C), 134.4, 139.3, 139.4, 139.6, 139.8, 144.3, 146.8; ppm; 31P NMR (121 MHz, 
CDCl3): δ = 17.8 ppm; IR (film): ν = 3374, 2979, 2918, 1600, 1499, 1440, 1347, 1233, 1160, 
1130, 1022, 961, 757, 693 cm-1; HRMS (ESI): calculated for C40H41O4PS2+H+ 681.2257; 
found: 681.2253.  
 
(E)-1-(3,4-Bis(5-chloro-2-methylthiophen-3-yl)-6-methylenecyclohex-3-en-1-yl)but-2-en-
1-ol (5e) 
The compound was prepared according to GP 1 yielding 32 % of 5d as brownish solid after 
purification by column chromatography on silica gel (Pentane/Et2O, 1:1 v/v). 1H NMR 
(300 MHz, CDCl3): δ = 1.77 (dd, J = 6.5, 1.6 Hz, 3H), 1.92 (s, 3H), 1.95 (s, 3H), 2.26-2.29 (m, 
1H), 2.55-2.58 (m, 2H), 3.15 (d, J = 19.7 Hz, 1H), 4.17 (t, J = 8.6 Hz, 1H), 5.04-5.08 (m, 2H), 
5.50 (ddd, J = 15.2, 8.3, 1.7 Hz, 1H), 5.72-5.81 (m, 1H), 6.42 (s, 1H), 6.52 (s, 1H) ppm; 13C 
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NMR (126 MHz, CDCl3): δ = 14.2, 14.3, 18.0, 35.1, 37.3, 48.1, 73.0, 112.1, 125.2, 125.3, 
126.7, 126.9, 129.8, 130.2, 130.5, 132.3, 133.0, 133.1, 137.9, 138.2, 144.3 ppm; IR (film): ν  
= 2920, 2240, 1950, 1854, 1800, 1670, 1601, 1499, 1420, 1380, 1340, 1210, 1120, 1090, 
970, 910, 829, 730, 680; 680 cm-1; HRMS (EI): calculated for C21H22OS2Cl2 424.0489; found 
424.0487. 
 
(3-(2,5-Dimethylthiophen-3-yl)-4-(2-methyl-5-phenylthiophen-3-yl)-6-methylene-
cyclohex-3-en-1-yl)(3-nitrophenyl)methanol (5g A) and (4-(2,5-dimethylthiophen-3-yl)-3-
(2-methyl-5-phenylthiophen-3-yl)-6-methylenecyclohex-3-en-1-yl)(3-nitrophenyl)-
methanol (5g B) 
The compound was prepared according to GP 1 yielding 30 % of 5g as brownish solid after 
purification by column chromatography on silica gel (Pentane/Et2O, 7:3 v/v). 1H NMR (500 
MHz, CDCl3): δ = 1.92 (s, 3H), 1.99 (s, 3H), 2.00 (s, 3H), 2.03 (dd, J = 17.2, 2.1 Hz, 2H), 2.07 
(s, 3H), 2.29 (s, 3H), 2.36 (s, 3H), 2.46-2.75 (m, 4H), 2.75-2.81 (m, 2H), 3.20 (t, 2H, J = 19.5 
Hz), 3.39 (t, J = 19.7 Hz, 2H), 4.95 (d, J = 9.7 Hz, 2H), 5.21 (s, 2H), 5.22 (s, 2H), 6.25 (d, J = 
0.9 Hz, 1H), 6.44 (d, J = 0.9 Hz, 1H), 6.78 (s, 1H), 6.98 (s, 1H), 7.19-7.26 (m, 2H), 7.30-7.37 
(m, 4H), 7.39-7.42 (m, 2H), 7.47-7.51 (m, 2H), 7.52-7.57 (m, 2H), 7.72 (t, J = 6.6 Hz, 2H), 
8.16-8.20 (m, 2H), 8.32-8.28 (m, 2H) ppm; 13C NMR (126 MHz, CDCl3): δ = 14.3, 14.4, 14.5, 
14.6, 15.2, 15.3, 34.9, 37.2, 37.3, 50.5 (2C), 73.4, 113.1 (2C), 122.4, 122.5, 123.2, 123.9, 
124.1, 125.3, 125.4, 125.7, 125.9, 127.2,  128.6, 128.9, 129.6 (2C), 129.7, 129.8, 130.9, 
131.9,  132.2, 133.4, 133.5, 134.2, 134.4, 134.5, 134.6, 135.5, 135.6, 137.9, 138.0, 139.5, 
139.6, 139.7, 144.2 (2C), 144.5, 148.5, 148.6 ppm; IR (film): ν  = 3543, 3069, 2917, 2857, 
1698, 1651, 1598, 1530, 1500, 1440, 1349, 1314, 1205, 1145, 1088, 1047, 901, 814, 758, 
691; HRMS (ESI): calculated for C31H29NO3S2 550.1481; found 550.1482. Regioisomeric 
ratio: 5g A : 5g B = 59:41 %. 
3.4.3 Immobilization 
Diarylcyclohexene 5d (100 mg, 0.15 mmol) was dissolved in dichloromethane (20 mL) and 
silica gel (100 mg, 0.04 – 0.063 mm) was added. The mixture was stirred over night at r.t. 
and then the silica gel was filtered off, washed with DCM (4 x 5 mL) and EtOH (4 x 5 mL) 
until the rinsing solution showed no UV-absorption after irradiation with UV-light (312 nm). 
After drying, the amount of immobilized compound 7 was determined by elementary analysis 
to be 2.2 · 10-5 mmoldye/mgsilicagel.   
 
Preparation of a photoswitchable paint 
Poly-2-ethyloxazoline (100 mg, Aquazol 200: molecular weight = 200.000 g/mol) was 
dissolved in water (2.0 mL), the coated silica gel (100 mg) was suspended and after stirring a 
jellylike gel was obtained.  
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Preparation of a photoswitchable cellulose sheet 
The diarylcyclohexene 5c (100 mg, 0.15 mmol) was dissolved in dry THF (20 mL) under 
nitrogen atmosphere. Then K2(CO3) (56 mg, 0.4 mmol) and cycanuric chloride (27 mg, 0.15 
mmol) were added and the mixture was stirred over night at r.t. Finally the solvent was 
evaporated and the residue was purified by silicagel column chromatography (PE/EE, 9:1 
v/v). A red oil (90 mg) was obtained which contained traces of unidentified by-products. 
Finally the roughly purified reactive dye was dissolved in dry DMF (20 mL) under nitrogen 
atmosphere. Then K2(CO3) (38 mg, 0.28 mmol) and a cellulose tissue were added to the 
mixture and the solution was heated to 60 °C over night. The cellulose tissue was washed 
with DCM, EtOH and aceton until no coloration of the rinsing solution was detected after 
irradiation with UV-light. 
Table 2. Immobilization of diarylcyclohexene 5c on cellulose. 
Cellulose sheet 
before 
immobilization 
[mg] 
Cellulose-sheet 
after 
immobilization 
[mg] 
Immobilized 
dye [mg] 
Immobilized 
dye [mmol] 
Dye[mmol]/cellulose 
[mg] 
176 198 22 3.7∙10-2 2.1∙10-4 
170 208 38 6.5∙10-2 3.8∙10-4 
195 230 35 5.9∙10-2 3.0∙10-4 
Midpoint: 3.0∙10-4 mmoldye/mgcellulose 
Standard aberration: 0.8∙10-4  mmoldye/mgcellulose 
Immobilization (%) = 5.2 (Assumption: only the primary hydroxyl group is reactive)  
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Chapter 4 
 
 
 
New GABA-Amides Activating GABAA 
 
We have prepared a series of new and some literature reported GABA-amides and 
determined their effect on the activation of GABAA-receptors expressed in CHO cells. Special 
attention was paid to the purification of the target compounds to remove even traces of 
GABA contaminations, which may arise from deprotection steps in the synthesis. GABA-
amides were previously reported to be partial, full or superagonists. In our hands, these 
compounds were not able to activate GABAA-receptor channels at whole cell patch-clamp 
recordings. New GABA-amides, however, gave moderate activation responses with a clear 
structure activity relationship suggesting some of these compounds as promising molecular 
tools for the functional analysis of GABAA-receptors. 
 
The results of this chapter are published: 
 
Raster, P.; Späth, A.; Bultakova, S.; Gorostiza, P.; König, B.; Bregestovski, P. Beilstein J. 
Org. Chem. 2013, 9, 406.  
 
Dr. Andreas Späth synthesized and characterized Boc-Pyrrolidone 1 and GABA-amide 
hydrochlorides 4a and 7c. Svetlana Bultakova performed the transient transfection of CHO-
cells and the electrophysiological recording.  
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4.1 Introduction 
The γ-aminobutyric acid (GABA) is the major inhibitory amino acid transmitter of the central 
nervous system (CNS) of vertebrates (Figure 1).  
 
Figure 1. The neurotransmitter GABA. 
It plays an important role in a variety of physiological functions, including motion control, 
vision, relaxation, sleep and many other brain functions.1-3 In vertebrates GABA activates 
specific receptors of several classes: GABAA, GABAB and GABAC.4 GABAA-receptors are 
transmembrane heterooligomeric proteins, forming Cl- selective channels and are composed 
of five subunits: two α, two β and one γ subunit.5 Being highly expressed in the peripheral 
and central nervous system GABAA-receptors represent a key therapeutic target for 
benzodiazepines, barbiturates, neurosteroids and general anesthetics.6-8 Therefore, in spite 
of a large variety of existing agonists, antagonists and modulators of GABA-receptors, there 
is a high interest in the development of new drugs which can interact with these targets. 
Many compounds of different substance classes are known to modulate the activity of 
GABAA-receptors.9-12 One substance group that has been less explored is GABA-amides. 
Compounds 4a, 4b, 4c, 7a (as triflate salt) and 7c are previously reported to potently activate 
the GABAA-channels being "partial, full or superagonists". However, in their work the authors 
studied the activity of GABA-amides on GABAA-receptors using chloride flux assays on 
synaptoneurosomes. Such preparations can contain many damaged cells leading to highly 
variable intracellular Cl- distribution in different cells.  In our study we used the patch-clamp 
technique, which is much more reliable and informative in comparison to the approach based 
on chloride flux assays. Like Carlier et al.,13 we noticed that in the course of the GABA-amide 
synthesis, GABA impurities are generated in the deprotection step. However, in contrast to 
Carlier et al.,13 who used a modification of Sallers`s procedure14 (detection limit < 0.1 wt%) to 
check the purity of the compounds, we have developed a improved purification procedure 
and used a more sensitive HPLC-MS analysis to ensure that the GABA-amide products do 
not contain any detectable amount of GABA (detection limit < 0.002 wt%). Our observations 
may help to give a more complete picture on the ability of GABA-amides to activate GABAA- 
receptors.  
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4.2 Results and Discussion 
4.2.1 Synthesis 
Boc-Pyrrolidone 1 was nucleophilic ring-opened by diamines 2a–c or the mono Boc-
protected diamines 5a-f in THF (Scheme 1).  
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Scheme 1. Synthesis of GABA-amide hydrochlorides 4a-c and 6a-f. i) THF, reflux; ii) MeOH, 
HCl (5 %); iii) THF, reflux; iv) MeOH, HCl (5 %).  
To cleave the Boc-protecting groups, the compounds were deprotected in dilute HCl 5 % 
(EtOH/H2O). It was observed that the use of more concentrated HCl can cause the cleavage 
of the amide-bonds and the release of free GABA. To remove any impurities of GABA, which 
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may falsify testing results, all substances were carefully purified: In a first purification step the 
GABA-amide hydrochlorides were dissolved in MeOH and precipitated by slow addition of 
Et2O. The precipitates were centrifuged and recrystallized several times from MeOH until no 
traces of GABA could be detected by HPLC-MS analysis. To determine the sensitivity of the 
analysis method three stock solutions of GABA were prepared (10-3, 10-5 and 10-7 mol/L) and 
1 µL was injected in the HPLC coupled mass spectrometer. On the basis of the obtained 
mass spectra a GABA detection limit of 0.14 pmol (14 pg) was determined.  
4.2.2 Electrophysiological Recording 
By examining the chloride Cl- uptake elicited by different GABAA-receptor agonists, Carlier et 
al. demonstrated that compounds with general structure 4a-c were capable to stimulate Cl- 
uptake with different efficacy.13 Moreover, the authors described compound 4b as 
"superagonist", because it induced maximal uptake about 50% higher than that achieved by 
GABA. Surprisingly, EC50 value for this compound was more than 30-fold higher than for 
GABA, i.e., at 733 µM and 14.3 µM, respectively. The investigations in this study were 
performed using a standard 36Cl--flux assay in mouse brain synaptoneurosomes. This 
technique does not allow a comparative analysis on one cell. Moreover, 36Cl--flux assays 
were carried out using a 15-s incubation time. As GABA-receptors usually exhibit strong 
desensitization at long exposures to agonists, we decided to re-examine these results using 
patch-clamp recordings and fast perfusion technique for the application of the tested 
compounds. The activity of synthesized compounds was tested using CHO cells transiently 
expressing GABAA-receptors in the configuration (α1-GFP+ β2 + γ2Long). To analyze the 
functional properties of the compounds we performed monitoring of ionic currents using 
whole-cell patch-clamp techniques. First, concentration-response curves for GABA were 
obtained and its EC50 was determined. Then we applied different concentrations of the 
studied compounds and estimated the minimal concentration that induced currents and, if 
possible, their EC50. The EC50 for GABA varied in different cells from 4 µM to 15 µM with a 
mean of 9.5 ± 0.3 µM (n = 10) (Figure 2).  
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Figure 2. Effect of 7b on GABAA-receptor activation. (A) Superimposed traces of whole-cell 
currents induced by rapid application of GABA (left) or compound 7b (right) in CHO cells 
transfected with α1-GFP/β2/γ2L combination of GABAA-receptor subunits; (B) Concentration 
dependecies of GABA (closed squares) and 7b (closed circles). EC50s were 12 µM and 10 
mM for GABA and 7b, respectively. 
Surprisingly, in contrast to previously described observations, our purified compounds 4a-c 
were not able to activate GABAA-receptors in concentrations up to 10 mM. Figure 3 illustrates 
this for the compound 4c.  
 
Figure 3. Absence of GABAA-receptor activation on application of 4c. Top traces: Examples 
of whole-cell currents on rapid application of 4c on CHO cells transfected with an α1-
GFP/β2/γ2L combination of GABAA-receptor subunits. Note that the compound was not able to 
induce currents even at a concetration of 15 mM. 
Similar results were obtained also for compounds 4a and 4b: on application of 10 mM, the 
changes in the current were 0 pA, (x = 4 for each compound). In contrast, all studied 
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compounds from series 7a-e were capable to induce ionic currents with different efficacy 
(Figure 4).  
,  
Figure 4. Variation of EC50 values with the number n of methylene units separating the 
amide and the ammonium group in compounds 7a-e. Each column represents results from 3-
7 cells. The mark [?] on the top of bars indicates that for the EC50s for these compounds 
were not determined precisely. 
Thus, compound 7a (n = 2) activated currents at 2.6 mM with an amplitude of 10-30 pA (x = 
4). The compound 7b (n = 3) activated GABA-receptors more strongly and at concentrations 
of 10 mM induced currents comparable to those for GABA 30-100 µM (Figure 2). The EC50 
for the compound 7b is 1080 ± 140 µM (x = 4). The efficacy of the compounds is significantly 
weaker than for GABA. The number of -CH2-units between the amide nitrogen atom and the 
ammonium moiety of compounds 7 affects the efficacy significantly, reaching a maximum 
with compound 7c (n = 4). The EC50 for compound 7c is 1750 ± 330 µm (x = 7). Compound 
7d (n = 6) also effectively activated GABAA-receptors with an activation threshold of about 
100 µM. At concentrations of 10 mM it caused currents similar of those induced by saturated 
GABA concentrations (30-100 µM) with an EC50 of about 5 mM (Figure 5A-C). The EC50 for 
compound 7d is 5250 ± 560 µM (x = 6). Kinetics of desensitization and the current-voltage 
dependencies (Figure 5D) of the studied compounds are similar to those for GABA. 
Compound 7e (n = 8) weakly activated currents at 5 mM with an amplitude of 10-20 pA (x = 
3). 
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Figure 5. Effect of 7d on GABAA-Receptor activation. (A, B) Superimposed traces of whole-
cell currents induced by rapid application of GABA (A) of the compound 7d (B) in CHO cells 
transfected with an α1-GFP/β2/γ2L combination of GABAA-receptor subunits; (C) 
Concentration dependencies obtained on application of GABA (red closed square) and 7d 
(black closed circles). EC50 values were 10.2 µM and 5.1 mM for GABA and 7d, respectively; 
(D) Current-voltage relations for responses induced by compound 7d. Insert: examples of 
traces at different membrane potentials. Scales: 2 nA and 1s.   
4.3 Conclusion 
Our data suggest that compounds 4a-c are not capable of activating GABAA-receptors. 
Compounds 7a-e are able to simulate these receptors and show a distinct structure-activity 
correlation. The compounds may become useful as molecular tools for the functional 
analysis of GABAA-receptors.  
4.4 Experimental 
4.4.1 General Experimental Conditions 
The following compounds were prepared according to literature methods: tert-butyl-2-
oxopyrrolidine-1-carboxylate (1),15 tert-butyl (2-aminoethyl)carbamate (5a),16 tert-butyl (3-
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aminopropyl)carbamate (5b),17 tert-butyl (4-aminobutyl)carbamate (5c),18 tert-butyl (6-
aminohexyl)carbamate (5d),17 tert-butyl (8-aminooctyl)carbamate (5e),17 tert-butyl-4-
(aminomethyl)-benzylcarbamate (5f).19 All other reagents were obtained from commercial 
sources. Unless otherwise noted, solvents (analytical grade) were purchased from 
commercial suppliers and used without further purification. Melting points were obtained 
using a Lambda Photometrics Optimelt MPA 100 apparatus (Lambda Photometrics 
Harpenden, UK), and are not corrected. IR spectra were obtained using a Varian 3000 
spectrometer. 1H-NMR spectra were recorded at 300 MHz on a Bruker Avance 300 
spectrometer. 13C-NMR spectra were recorded at 75 MHz on a Bruker Avance 300 
spectrometer. The NMR spectra were recorded in CDCl3, DMSO or MeOD as solvent and 
chemical shifts are reported in ppm. Mass spectra were obtained using Finnigan SSQ 710A 
(EI), Finnigan MAT 95 (CI) or Finnigan MAT TSQ 7000 (Thermo FINNIGA, USA) (ES/LS-
MS)] instrumentation. Thin layer chromatography (TLC) was performed on alumina plates 
coated with silica gel (Merck silica gel 60 F245, thickness 0.2 mm). Column chromatography 
was accomplished with Merck Geduran SI 60 silica gel as the stationary phase. Petroleum 
ether (PE) refers to the fraction boiling at 30-60 °C. 
4.4.2 Synthetic Protocols and Analytical Data of 3a-c, 4a-c, 6a-f and 7a-f  
Boc-protected GABA-amides 3a-c; General Procedure (GP 1) 
Boc-pyrrolidone 1 (5 mmol, 0.86 g) was dissolved in abs. THF (5 mL) and the diamines 2a–c 
(2.5 mmol) were added. The solution was stirred under reflux and nitrogen atmosphere until 
the diamines were completely converted as monitored by TLC. The solvent was evaporated, 
the crude product was purified by flash chromatography (EE) and white solids were obtained.  
 
Di-tert-butyl ((butane-1,4-diylbis(azanediyl))bis(4-oxobutane-4,1-diyl))dicarbamate (3a)  
The compound was prepared according to GP 1 yielding 92 % (1.05 g) of the target product. 
Analytics is in good agreement to literature reported values.13 
 
Di-tert-butyl ((hexane-1,6-diylbis(azanediyl))bis(4-oxobutane-4,1-diyl))dicarbamate (3b) 
The compound was prepared according to GP 1 yielding 90 % (1.09 g) of the target product. 
Analytics is in good in agreement to literature reported values.13 
 
Di-tert-butyl ((octane-1,8-diylbis(azanediyl))bis(4-oxobutane-4,1-diyl))dicarbamate (3c) 
The compound was prepared according to GP 1 yielding 88 % (1.10 g) of the target product. 
 
Diamines 4a-c; General Procedure (GP 2) 
The Boc protected diamines 3a-c (1 mmol) were dissolved in EtOH (10 mL), a HCl solution 
(5 %, 20 ml) was added over a period of 2 – 3 h, and the reaction progress was monitored by 
New GABA-Amides Activating GABAA 
41 
TLC. A second portion of aqueous HCl (0.5 M, 100 mL) was added if necessary, and the 
solution was stirred until the deprotection was completed. EtOH was evaporated and the 
remaining H2O was removed by lyophilisation. The product was recrystallised from MeOH 
twice. Drying in vacuo afforded the deprotected amine hydrochlorides as colorless, white 
solids. Analytics is in good agreement to literature reported values.13 
 
N,N´-(Butane-1,4-diyl)bis(4-aminobutanamide) dihydrochloride (4a) 
The compound was prepared according to GP 2 yielding 48 % (168 mg) of the target 
compound. Analytics is in good agreement to literature reported values.13 
 
N,N´-(Hexane-1,6-diyl)bis(4-aminobutanamide) dihydrochloride (4b) 
The compound was prepared according to GP 2 yielding 55 % (179 mg) of the target 
compound. Analytics is in good agreement to literature reported values.13 
 
N,N´-(Octane-1,8-diyl)bis(4-aminobutanamide) dihydrochloride (4c)  
The compound was prepared according to GP 2 yielding 40 % (154 mg) of the target 
compound. 13 
 
Boc protected GABA-amides 6a-f; General Procedure (GP 3) 
N-Boc-pyrrolidone 1 (1.85 g, 10 mmol) and the mono Boc-protected amines (5a-f) (15 mmol) 
were dissolved in THF (10 mL) and the solution was refluxed for 2 d. The solvent was 
evaporated and the residue was dissolved in dichloromethane (30 mL). The organic layer 
was washed with H2O (20 mL) and brine (20 mL), dried over MgSO4 and the solvent was 
evaporated. The raw material was purified by column chromatography (EE/PE, 1:1 v/v  3 : 
1) to give colorless solids. 
 
4-(tert-Butyloxycarbonyl-amino)-N-(2-(tert-butyloxycarbonyl-amino)ethyl)butanamide 
(6a)  
The compound was prepared according to GP 3 yielding 91 % (3.10 g) of the target 
compound. Analytics is in good agreement to literature reported values.13 
 
4-(tert-Butyloxycarbonyl-amino)-N-(3-(tert-butyloxycarbonyl-amino)propyl)butanamide 
(6b) 
The compound was prepared according to GP 3 yielding 88 % (3.15 g) of 6b as a white solid, 
mp 80-82 °C. 1H NMR (300 MHz, CDCl3): δ = 1.27-1.30 (m, 4H), 1.40-1.57 (m, 14H), 1.64-
1.87 (m, 4H), 2.18 (t, J = 6.8 Hz, 2H), 3.04-3.26 (m, 6H), 4.47 (s, 1H), 4.80 (s, 1H), 6.20 (s, 
1H) ppm; 13C NMR (75 MHz, CDCl3): δ = 26.8, 27.5, 27.6, 28.8, 30.4, 34.4, 40.8, 41.4, 79.4, 
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79.6, 155.8, 155.9, 172.5 ppm; IR (film): ν  = 3430, 3230, 3080, 3050, 2940, 2970, 2870, 
2803, 2744, 2635, 2383, 2340, 2032, 1779, 1682, 1611, 1539, 1482, 1386, 1349, 1310, 
1284, 1260, 1213, 1152, 1068, 1019, 976 cm-1; HRMS (EI): calculated. for C17H33N3O5 
359.2420; found 359.2425. 
 
4-(tert-Butyloxycarbonyl-amino)-N-(4-(tert-butyloxycarbonyl-amino)butyl)butanamide 
(6c) 
The compound was prepared according to GP 3 yielding 86 % (3.06 g) of the target 
compound. Analytics is in good agreement to literature reported values.13 
 
4-(tert-Butyloxycarbonyl-amino)-N-(6-(tert-butyloxycarbonyl-amino)hexyl)butanamide 
(6d) 
The compound was prepared according to GP 3 yielding 90 % (3.21 g) of 6d as a white solid, 
mp 82-84 °C. 1H NMR (300 MHz, CDCl3): δ = 1.27-1.31 (m, 4H), 1.40-1.55 (m, 20H), 1.66 – 
1.85 (m, 4H), 2.20 (t, J = 6.9 Hz, 2H), 3.04-3.28 (m, 6H), 4.50 (s, 1H), 4.77 (s, 1H), 6.18 (s, 
1H) ppm; 13C NMR (75 MHz, CDCl3): δ = 26.8, 27.5, 27.7, 28.8, 30.4, 30.9, 34.5, 40.4, 40.9, 
41.3, 41.5, 79.5, 79.6, 155.8 155.9, 172.6 ppm; IR (film): ν  = 3437, 3231, 3085, 3053, 2944, 
2972, 2874, 2803, 2744, 2629, 2585, 2383, 2335, 2032, 1779, 1682, 1611, 1539, 1482, 
1386, 1349, 1310, 1284, 1263, 1213, 1152, 1068, 1019, 976, 909 cm-1; HRMS (ESI): 
calculated for C20H39N3O5 401.2890; found 401.2895. 
 
4-(tert-Butyloxycarbonyl-amino)-N-(8-(tert-butyloxycarbonyl-amino)octyl)butanamide 
(6e)  
The compound was prepared according to GP 3 yielding 85 % (3.65 g) of 6e as a white solid, 
mp 92-94 °C. 1H NMR (300 MHz, CDCl3): δ = 1.41-1.51 (m, 26H), 1.75-1.85 (m, 4H), 2.16-
2.23 (d, J = 6.9 Hz, 2H), 3.05-3.26 (m, 8H), 4.52 (s, 1H), 4.77 (s, 1H), 6.16 (s, 1H) ppm; 13C 
NMR (75 MHz, CDCl3): δ = 27.5, 27.7, 28.3, 28.4, 29.3, 29.4, 26.7, 26.8, 26.4, 26.2, 39.2, 
39.5, 40.3, 79.5, 79.6, 155.9, 155.8, 172.6 ppm; IR (film): ν  = 3353, 2970, 2936, 2868, 1682, 
1640, 1517, 1446, 1388, 1364, 1298, 1270, 1249, 1162, 1102, 999, 984, 870 cm-1; HRMS 
(EI): calculated for C22H43N3O5 429.3203; found 429.3200. 
 
4-(tert-Butyloxycarbonyl-amino)-N-(4-(tert-butyloxycarbonyl)amino)benzyl)butanamide 
(6f) 
The compound was prepared according to GP 3 yielding 88 % (2.96 g) of 6f as a white solid, 
mp 124–126 °C. 1H-NMR (300 MHz, CDCl3): δ = 1.41-1.43 (s, 9H), 1.44-1.46 (s, 9H), 1.76-
1.88 (q, J = 6.7 Hz, 2H), 2.20-2.28 (t, J = 7.1 Hz, 4H), 3.10–3.20 (m, 2H), 4.24-4.30 (d, J = 
5.9 Hz, 2H), 4.38-4.44 (d, J = 5.8 Hz, 4H), 4.79 (s, 1H), 4.85 (s, 1H), 6.45 (s, 1H), 7.23 (m, 
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4H) ppm; 13C NMR (75 MHz, CDCl3): δ = 26.8, 27.4, 27.6, 27.7, 28.8, 34.4, 40.1, 43.9, 44.8, 
80.0, 80.2, 128.4, 128.7, 138.79, 140.0, 158.6, 175.4, 175.5 ppm; IR (film): ν  = 3340, 2973, 
2936, 2882, 1678, 1643, 1531, 1463, 1445, 1389, 1364, 1266, 1208, 1100, 1052, 1027, 990, 
897, 874, 837, 804 cm-1; HRMS (EI): calculated for C22H35N3O5 421.2577; found 421.2576. 
 
Diamines (7a–f); General Procedure (GP 4) 
The Boc-protected diamines 6a-f (1 mmol) were dissolved in EtOH (10 mL). Aqueous HCl 
(0.5 %, 20 mL) was slowly added, and stirring was continued over night. EtOH was 
evaporated, and the remaining H2O was removed by lyophilisation. The residue was 
dissolved in warm EtOH (30 mL), the product was precipitated by careful addition of Et2O 
and then centrifuged, and the supernatant was decanted off. Recrystallisation from MeOH 
and drying in vacuo afforded the deprotected amine hydrochlorides as colourless solids.  
 
4-Amino-N-(2-aminoethyl)butanamide dihydrochloride (7a) 
The compound was prepared according to GP 4 yielding 60 % (130 mg) of 7a as a white 
solid, mp 144-146 °C. 1H NMR (MeOD, 300 MHz): δ = 1.85-1.99 (q, 2H), 2.38–2.47 (t, 2H, 
7.2 Hz), 2.90 (t, J = 7.0 Hz, 2H), 3.08 (t, J = 7.3 Hz, 2H), 3.48 (t, J = 7.0 Hz, 2H) ppm; Amine 
and amid protons are not detected due exchange effects with the solvent (5H); 13C NMR 
(DMSO, 75 MHz): δ = 24.5, 24.7, 54.8, 113.2, 130.3, 174.4 ppm; IR (film): ν  = 3430, 3251, 
3085, 3053, 2944, 2383, 2335, 2032, 1779, 1682, 1611, 1539, 1482, 1386, 1349, 1213, 
1152, 1068, 1019, 976, 909 cm-1; HRMS (EI): calculated for C6H15N3O 145.1215; found 
145.1217. 
 
4-Amino-N-(3-aminopropyl)butanamide dihydrochloride (7b) 
The compound was prepared according to GP 4 yielding 45 % (104 mg) of 7b as a white 
solid, mp 140-142°C. 1H NMR (D2O, 300 MHz): δ = 1.72-1.91 (m, 4H), 2.28 (t, J = 7.2 Hz, 
2H), 2.90 (m, 4H), 3.20 (t, J = 7.0 Hz, 2H) ppm; Amine and amid protons are not detected 
due exchange effects with the solvent (5H); 13C NMR (DMSO, 75 MHz): δ = 24.5, 33.8, 37.1, 
54.2, 110.2, 124.4, 174.4 ppm; IR (film): ν  = 3430, 3231, 3075, 3053, 2972, 2940, 2874, 
2803, 2744, 2629, 1779, 1682, 1611, 1534, 1492, 1386, 1340, 1310, 1284, 1263, 1019, 976, 
909 cm-1; HRMS (EI): calculated for C7H17N3O 159.1371; found 159.1374. 
 
4-Amino-N-(4-aminobutyl)butanamide dihydrochloride (7c) 
The compound was prepared according to GP 4 yielding 55 % (138 mg) of 7c.13 
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4-Amino-N-(6-aminohexyl)butanamide dihydrochloride (7d) 
The compound was prepared according to GP 4 yielding 50 % (147 mg) of 7d as a white 
solid, mp 147-150 °C; 1H NMR (MeOD, 300 MHz) δ = 1.34-1.48 (m, 4H), 1.49-1.60 (m, 2H), 
1.62-1.74 (m, 2H), 1.87-1.99 (q, J = 7.3 Hz, 2H), 2.34-2.41 (t, J = 7.2 Hz, 2H), 2.87-3.01 (m, 
4H), 3.16-3.23 (t, J = 7.0 Hz, 2H); amine and amid protons are not detected due exchange 
effects with the solvent (5 H); 13C NMR (DMSO, 75 MHz): δ = 24.5, 24.7, 30.5, 32.3, 33.8, 
37.1, 48.2, 110.2, 130.3, 174.5 ppm; IR (film): ν  = 3437, 3231, 3085, 3053, 2972, 2944, 
2874, 2803, 2744, 2629, 2585, 2383, 2335, 2032, 1779, 1682, 1611, 1539, 1482, 1386, 
1349, 1310, 1284, 1263, 1213, 1152, 1068, 1019, 976, 909 cm-1; HRMS (EI): calculated for 
C10H23N3O 201.1841; found 201.1845.  
 
4-Amino-N-(8-aminooctyl)butanamide dihydrochloride (7e) 
The compound was prepared according to GP 4 yielding 40 % (120 mg) of 7e as white solid, 
mp 136-138 °C. 1H NMR (MeOD, 300 MHz) δ = 1.30-1.45 (m, 8H), 1.46-1.58 (m, 2H), 1.59-
1.72 (m, 2H), 1.86-1.98 (q, J = 7.3 Hz, 2H), 2.34-2.40 (t, J = 7.1 Hz, 2H), 2.87-3.00 (m, 4H), 
3.14-3.22 (t, J = 7.1 Hz, 2H) ppm; amine and amid protons are not detected due exchange 
effects with the solvent (5 H); 13C NMR: δ = 24.6, 27.4, 27.9, 28.6, 30.0, 30.1, 33.8, 40.8, 
49.1, 113.4, 127.8, 171.2 ppm; IR (film): ν  = 3347, 3329, 3126, 3080, 3046, 2973, 2941, 
2892, 2862, 2813, 2740, 2380, 2175, 2020, 1681, 1611, 1540, 1484, 1384, 1349, 1311, 
1284, 1262, 1240, 1197, 1152, 1065, 1011, 976, 939, 893, 839 cm-1; HRMS (EI): calculated 
for C12H27N3O 229.2154; found 229.2160.   
 
4-Amino-N-(4-(aminomethyl)benzyl)butanamide dihydrochloride (7f)  
The compound was prepared according to GP 4 yielding 50 % (168 mg) of 7f as a white 
solid, mp 251-253 °C. 1H NMR (MeOD, 300 MHz): δ = 1.89-2.01 (q, 2H, J = 7.3 Hz, 2H), 
2.38-2.46 (t, J = 7.1 Hz, 2H), 2.94-3.01 (t, 2H, J = 7.4 Hz), 4.10 (s, 2H), 4.39 (s, 2H), 7.34–
7.46 (m, 4H) ppm; Amin and amid protons are not detected due exchange effects with the 
solvent (5H); 13C NMR (DMSO, 75 MHz): δ = 24.5, 33.7, 40.5, 43.8, 44.2, 114,1, 125,3 
129.3, 130.3, 133.4, 141.3, 174.5 ppm; IR (film): ν  = 3340, 3279, 2972, 2939, 2880, 2361, 
2174, 2048, 1678, 1624, 1536, 1505, 1463, 1423, 1388, 1364, 1299, 1266, 1248, 1161, 
1099, 1053, 1027, 989, 896, 875, 836 cm-1; HRMS (EI): calculated for C12H19N3O 221.1528; 
found 221.1530. 
4.4.3 Cell Culture and Transient Transfection   
Chinese Hamster Ovary (CHO-K1) cells were obtained from the American Type Tissue 
Culture Collection (ATCC, Molsheim, France) and maintained as previously described.20,21 
One day before the transfection, cells were plated on the coverslips (12-14 mm in diameter), 
which were placed inside 35 mm cell culture dishes with 2 ml of medium. CHO cells were 
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transfected with a total 3 µg cDNA of α1-GFP + β2 + γ2Long (ratio 1:1:1) using the 
Lipofectamine 2000 transfection protocol (Life Technology, USA). Three hours after the initial 
exposure of the cells to the cDNAs, a fresh cDNA-containing solution replaced the old one. 
Electrophysiological recordings were performed from fluorescent cells 48-72 hours after 
transfection. 
4.4.4 Biology - Electrophysiological Recording 
Whole-cell recordings were conducted on CHO-K1 cells at room temperature (20-25 °C) 
using an EPC-9 amplifier (HEKA Elektronik, Germany). Cells were continuously superfused 
with external solution containing (mM): NaCl 140, CaCl2 2, KCl 2.8, MgCl2 1, HEPES 20, 
glucose 10; pH 7.3; 320-330 mOsm. The patch pipette solution contained (mM): CsCl 140, 
MgCl2 2, MgATP 2, NaGTP 0.4, HEPES/CsOH 10, BAPTA/KOH 20; pH 7.3; 290 mOsm. 
Pipettes were pulled from borosilicate glass capillaries (Harvard Apparatus Ltd, USA) and 
had resistances of 5-8 MOhms. For rapid replacement of solutions, a system of two parallel 
rectangular tubes, 100 µm in diameter, located at a distance of 40-50 µm from the tested cell, 
was used. The movement of tubes was controlled by a computer-driven fast exchange 
system (SF 77A Perfusion Fast-Step, Warner, USA). As measured by open tip electrode 
controls (1/10 NaCl), in this system a 20-80% solution exchange time was within 2-3 ms. 
Cells with a low input resistance (<150 MOhms) were excluded from analysis. For 
quantitative estimations of agonist action, dose-response relationships were fitted by the 
equation: 
I = Imax / (1 + (EC50 / [C])n) 
I is the current amplitude induced by the agonist at concentration [C], Imax is the maximum 
response of the cell, n is the Hill coefficient and EC50 is the concentration for which a half-
maximum response is induced. Concentration-response relationships were constructed using 
at least four points.  
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Chapter 5 
 
 
 
Photoswitchable GABAA-Receptor Ligands  
 
We have synthesized a series of photoswitchable benzodiazepine derivatives and the effect 
on GABAA-receptor activation was determined by whole cell patch-clamp recording and by 
two electrode voltage clamp in Xenopus oocytes. Two compounds showed moderate 
potentiation of the GABA induced current, but the observed extent was different in the two 
systems. UV-irradiation experiments gave no interpretable results, because of the insufficient 
solubility of the compounds. Therefore, a more polar and better water soluble 
benzodiazepine derivative was synthesized and the effect of GABAA-receptor activation was 
determined. The test results to this point are inconsistent and additional experiments are 
ongoing.  
 
Natascha Kuzmanovic synthesized diarylethene derivatives 9 and 10 and performed the 
Suzuki coupling reactions for the synthesis of benzodiazepine derivatives 2-4 and 21. 
Svetlana Bultakova and Galina Maleeva (Marseille, France) transiently transfected CHO-
cells and did the electrophysiological recording. Xenopus surgery, expression of recombinant 
rat α1β2γ2 GABAA-receptors in Xenopus oocytes and functional characterization of these 
GABAA-receptors were performed by Simon Middendorp and Roland Baur. 
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5.1 Introduction 
GABAA-receptors are transmembrane heterooligomeric proteins forming chloride (Cl-) 
selective channels and are composed of five subunits: two α, two β and one ǳ subunit.1 
Highly expressed in the peripheral and central nervous system, GABAA-receptors represent a 
key therapeutic target for benzodiazepines, barbiturates, neurosteroids and general 
anesthetics.2-4 Binding of the endogenous neurotransmitter GABA induces channel opening 
and causes hyperpolarizing of postsynaptic neurons. Dysfunctions are related with several 
diseases like insomnia, schizophrenia, epilepsy and anxiety disorder.5 To explore the 
functions of the GABAA-receptor more detailed and to get a more complete picture about the 
role of this target, it would be helpful to have the possibility to activate single ionic channels. 
Up to now, different concepts like electronic stimulation, exposure to ultrasonic waves or 
irradiation with light are reported to trigger single ionic channels.6-8 Maybe, the most 
promising method to stimulate the activity of ionic channels is the use of light, as the 
activation can be spatially and temporally resolved.9 However, ionic channels are normally 
not light sensitive and cannot be activated directly by light. To stimulate ionic channels 
indirect, light sensitive compounds like “caged compounds” bearing photolabile protecting 
groups or photochromic ligands have been used.9 Caged compounds release a biologic 
active compound after irradiation with light. The limitation of these compounds is that the 
release process is irreversible and cannot be repeated. In contrast, photochromic 
compounds can be reversibly switched between two different photoisomers, which may 
exhibit different biological activity. Typically, the switching process can be repeated several 
times and therefore, photoswitchable compounds seem to be promising candidates for the 
synthesis of light sensitive ligands for biological targets like the GABAA-receptor. Recently, 
Trauner and coworkers reported the synthesis of a photoswitchable ligand for the GABAA-
receptor.8 As photoswitchable unit they used an azobenzene derivative. The use of this 
ligand was limited because of the thermal instability of the (Z)-isomer, which immediately 
switched back to the more stable E-(isomer) as soon as the light source was switched off 
(Figure 1).  
 
Figure 1. A photoswitchable ligand for the GABAA-receptor. The azopropofol derivative 1-Z is 
thermally not stable and switches immediately back to 1-E as soon the light source is 
switched off. 
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In our approach towards light sensitive ligands for the GABAA-receptor, we combined a 
diarylethene as photoswitchable unit with a benzodiazepine derivative as pharmacophore. 
Diarylethenes are a widely used photochromic class of substances, which show in many 
cases high fatigue resistance, complete photoisomerization and slow thermal interconversion 
of the photoisomers.10 Benzodiazepines are an important compound class among the broad 
variety of tranquilizers and can modulate the effect of the endogenous neurotransmitter 
GABA.11 Moreover, the structure-activity relationship of benzodiazepines is well studied and 
it is known that electron withdrawing substituents at the 2-position of the annulated benzene 
ring amplify the effect of benzodiazepines.12  
 
Figure 2. Structure-activity relationship of benzodiazepines. In general, the substitution of 
the 2-position of the annulated benzene ring by electron withdrawing groups (R1 = NO2 > Br > 
Cl> F = H) amplifies the activity of benzodiazepines. 
In a first series, we synthesized three benzodiazepine derivatives which were substituted by 
a diarylethene photoswitch at the 1 and 2 position (Figure 3).  
N
N
O
HSSR SSCl N
N
H O
3: R =2: R Cl
4
=
 
Figure 3. Photoswitchable benzodiazepine derivatives 2-4. 
In the open form 2(o), the pharmacophore is electronically separated from the electron 
withdrawing chloro substituent whereas in the closed form 2(c), the pharmacophore is in 
direct conjugation to the halogen atom. This is exemplarily shown for compound 2 in Figure 
4. Furthermore, the closed isomer 2(c) is more rigid, less flexible and sterically more 
hindered than the open isomer 2(o) and therefore, we expected different activities of the 
photoisomers.  
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Figure 4. Photoisomerization of benzodiazepine derivative 2(o) with UV-light. 
Reisomerization of 2(c) is induced by irradiation with visible light. 
5.2 Results and Discussion 
5.2.1 Synthesis of Photoswitchable Benzodiazepines 2, 3 and 4 
The synthesis of benzodiazepine derivatives 2 and 3 is illustrated in Scheme 1.  
 
Scheme 1. Synthesis of photoswitchable benzodiazepine derivatives 2 and 3. i) NaCl, NaIO4, 
KI, AcOH, H2O; ii) Cl(C=O)CH2Cl, CHCl3, NEt3; iii) NH4OAc, HMTM, EtOH; iv) 1.) 9 or 10, n-
BuLi, THF, -80° C 2.) B(OCH3)3 3.) 8, (NH4)2CO3, Pd(dppf)Cl2, THF. 
In a first step, 2-aminobenzophenone 5 was iodinated in an aromatic substitution reaction 
using iodine, NaIO4 and NaCl; the target compound 6 was obtained in 60 % yield. Secondly, 
compound 6 was acylated under basic conditions and gave compound 7 in 75 % yield. Next, 
compound 7 was ring closed with HMTM and NH4(OAc) affording benzodiazepine derivative 
8 in 60 % yield. Finally, benzodiazepine derivative 8 was converted in a Suzuki reaction with 
DTE derivatives 10 and 9 resulting in the cross coupling products 3 in satisfying 92 % yield. 
Compound 2 was obtained in moderate 66 % yield. The reason for the smaller yield of 
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compound 2 was the occurance of disubstitution and dehalogenation products, which were 
generated under the reaction conditions of the halogen lithium exchange. Apart from the first 
reaction step, the synthesis of benzodiazepine derivative 4 follows the previously described 
reaction route (Scheme 2). Compound 4 could not be completely purified and contained 
small amounts of the dehalogenated byproduct.  
 
Scheme 2. Synthesis of benzodiazepine derivative 4. i) BCl3, Bn-CN, AlCl3, C2H4Cl2; ii) 
Cl(C=O)CH2Cl, CHCl3, N(Et)3; iii) NH4OAc, HMTM, EtOH; iv) 1.) DTE 9, n-BuLi, THF, -80°C 
2.) B(OCH3)3, -80°C. 3.) (NH4)2CO3, Pd(dppf)Cl2, THF, -80°C. 
Aminobenzophenone derivative 12 was synthesized by a Friedel-Crafts acylation reaction of 
3-iodoaniline 11 with benzonitrile. The ortho acylation was performed in the presence of BCl3 
and AlCl3. The six membered transition state directs the reaction site of aniline-derivative 11 
ortho to the electrophilic center of benzonitrile (Figure 5).13 
 
Figure 5. Boron trichloride-catalyzed Friedel-Crafts-Acylation reaction of 3-iodoaniline and 
benzonitrile. 
5.2.2 Photoisomerization and Photobleaching of Benzodiazepine Derivatives 2, 3 and 4 
Compounds 2-4 photoisomerize in DMSO by irradiation with UV-light of 312 nm wavelength. 
This is exemplarily shown for compound 2 in Figure 6 (left). The closed diarylethenes 
isomerize quantitatively to the open form upon irradiation with a 200 W tungsten light source 
Photoswitchable GABAA-Receptor Ligands 
52 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
260 360 460 560 660
A
b
s
o
r
p
t
i
o
n
Wavelength [nm]
that was passed through a 420 nm cut-off filter to eliminate higher energy light. 
Benzodiazepine derivatives 2-4 photodegrade in solution. After 7 photoisomerization cycles, 
the absorption of the chromophore is reduced by half indicating about 50 % decomposition of 
the chromophore (Figure 6, right). 
 
Figure 6. Irradiation of benzodiazepine 2 with UV-light (312 nm) in DMSO. Left: UV 
absorption spectrum of compound 2 (c = 3.0·10-5 mmol/L in DMSO). Irradiation times were 
15, 30, 45 and 60 s. Right: Decreasing absorption at 530 nm of a solution of benzodiazepine 
derivative 2 in DMSO during photoisomerization. 
5.2.3 Electrophysiological Recording and Testing of Benzodiazepines 2,3 and 4 – 
Results from the Group of Prof. P. Bregestovski 
The activity of the synthesized compounds was tested by patch-clamp recording using CHO-
cells transiently expressing GABAA-receptors in the configuration α1-GFP/β/γ2L.The 
heterologously expressed GABAA-receptors were exposed to GABA at concentrations from 
3-10 µM in combination with compounds 2-4 (20-36 µM). The solubility of the compounds in 
aqueous buffer (1 % DMSO) was limited and the test solution showed scattering of laser light 
indicating that the compounds were not completely dissolved and aggregated. Therefore, the 
results are preliminary and qualitative illustrating only trends. The UV-irradiation experiments 
were not fully reproducible. Higher concentrations of DMSO are cell toxic and could therefore 
not be used. Compound 2 (36 µM) amplified the effect of GABA (3 µM) by about 60 ± 11% (n 
[number of tested cells] = 7) (Figure 7), whereas compound 3 (20 µM) was weaker and 
potentiated GABA (10 µM)-induced currents only by about 20 ± 7 % (n = 7).  
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Figure 7. Effect of benzodiazepine derivative 2 on GABAA-receptor activation. Superimposed 
traces of whole-cell currents induced by rapid application of GABA (3 µM) in combination 
with benzodiazepine derivative 2 (36 µM) in CHO cells transfected with α1-GFP/β2/γ2L 
combination of GABAA-receptor subunits.  
In contrast, compound 4 (27 µM) reduced GABA (10 µM)-induced currents by about 24 ± 5% 
(n=6). Figure 8 summarizes the test results.  
 
Figure 8. Effect of photoswitchable benzodiazepine derivatives 2-4 in combination with 
GABA on GABAA-receptor activation relative to pure GABA. 
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5.2.4 Electrophysiological Recording and Testing of Benzodiazepine 2 – Results from 
the Group of Prof. Sigel 
The effect of compound 2 on Cl- currents elicited by GABA was investigated using 
electrophysiological techniques in α1/β2/γ2 GABAA receptors expressed in Xenopus oocytes. 
Compound 2 (10 µM) potentiated currents elicited by GABA (1 µM) by about 280 % (n = 1). 3 
µM of the compound potentiated by 311 ± 51 % (mean ± SD, N = 5). The fact that 1 µM of 
the antagonist Ro15-1788 counteracted the potentiation indicates that compound 2 is a 
ligand of the benzodiazepine binding site. This was confirmed by displacement of [3H]Ro15-
1788 by compound 2 from GABAA receptor transiently transfected into HEK-cells with an Ki 
of 91 nM. This is surprising in view of the huge substituent replacing -Cl in diazepam. The 
above observations are in contrast to those made with the patch-clamp technique in another 
laboratory. The reasons for this discrepancy are not known. UV-irradiation experiments are 
still in progress. 
5.2.5 Synthesis of Benzodiazepine 21 
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Scheme 3. Synthesis of benzodiazepine derivative 21. i) , CuI, PPh3, Pd(Cl2)(PPh3)2, 
NEt3, THF; ii) NaCl, NaIO4, KI, AcOH, H2O; iii) MeOH, K2CO3; iv) Cl(C=O)CH2Cl, CHCl3, 
NEt3; v) NH4OAc, HMTM, EtOH; vi) R-N3, CuSO4, sodium ascorbate; vii) 1.) 9, n-BuLi, THF; 
2.) B(OCH3)3; 3.) (NH4)2CO3, 20, Pd(dppf)Cl2, THF, -80 °C. 
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Due to the insufficient solubility of compounds 2-4 in aqueous buffer, a better soluble 
derivative of benzodiazepine derivative 2 was synthesized (Scheme 3). The palladium-
catalyzed Sonogashira reaction of (2-aminophenyl)(4-bromophenyl)-methanone 15 with 
TMS-acetylene gave coupling product 16 in excellent 95 % yield. Reaction steps ii-v follow 
the previously described synthesis. To improve the solubility, a PEG-chain was attached to 
compound 19 using standard click chemistry yielding compound 20 in 57 %. Suzuki coupling 
of precursor 20 with DTE 9 afforded finally the target compound 21 in 63 % yield.  
5.2.6 Photoisomerization and Photobleaching of Benzodiazepine 21 
Compound 21 photoisomerizes in DMSO by irradiation with light of 312 nm wavelength 
(Figure 9, left). The closed isomer isomerizes quantitatively to the open form upon irradiation 
with a 200 W tungsten light source that was passed through a 420 nm cut-off filter to 
eliminate shorter wavelengths. The compound photodegrades in solution. After 8 
isomerization cycles the absorption of the chromophore at 520 nm is reduced by about 40 % 
(Figure 9, right).  
 
Figure 9. Irradiation of benzodiazepine derivative 21 with UV-light (312 nm) in DMSO. Left: 
UV-absorption spectrum of compound 21 (c = 3.0·10-5 mmol/L in DMSO). Irradiation of 
diarylcyclopentene 21 with UV-light (312 nm) in DMSO. Irradiation times were 15, 30, 45 and 
60 s. Right: Decreasing absorption at 530 nm of a solution of benzodiazepine derivative 21 in 
DMSO during photoisomerization.  
5.2.7 Electrophysiological Recording and Testing of Benzodiazepine 21 – Results of 
the Group of Prof. Bregestovski 
Compound 21 induced an inhibition of the GABA (5 µM) current. The inhibition was amplified 
by irradiation of the test solution with UV-light of 312 nm (Figure 10). 
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Figure 10. Effect of compound 21 on GABAA-receptor activation. Superimposed traces of 
whole-cell currents induced by rapid application of GABA (5 µM) (red line); GABA in 
combination with compound 21 (60 µM) (black line); GABA (5 µM) in combination with 21 (60 
µM) after irradiation with UV-light of 312 nm (blue line) in CHO cells transfected with α1-
GFP/β2/γ2L combination of GABAA receptor subunits. 
Table 1 summarizes the results of the study on different cells and concentrations of 
compound 21. 
Table 1. Effect of compound 21 on GABAA-receptor activation before and after 2 min UV-
irradiation with UV-light of 312 nm. 
Cell number Concentration of 21 
Inhibition of GABA 
induced current 
before irradiation % 
Inhibition of GABA 
induced current after 
irradiation % 
1 3 µM 0 11 
2 10 µM 0 16 
3 10 µM 6 18 
4 60 µM 40 80 
 
5.2.8 Electrophysiological Recording and Testing of Benzodiazepine 21 – Results of 
the Group of Prof. Sigel 
Compound 21 was determined as positive allosteric modulator of GABA induced current and 
potentiated the effect of GABA by about 54 % (n = 1) whereas higher concentrations of 
compound 21 (10 µM) only potentiated the effect of GABA by about 45 % (n = 1). For the  
closed isomer of compound 21 at both concentrations a potentiation of 21 % (n = 1) was 
found. As the observed potentiation was low, the group concentrated on compound 2 (see 
above). 
 
Photoswitchable GABAA-Receptor Ligands 
57 
5.3 Conclusion 
In a first series, three photoswitchable benzodiazepine derivatives were synthesized and 
their physiological activity was determined with patch-clamp recording in whole-cell 
configuration. Two compounds out of the first series showed moderate ampflification of 
GABA induced current, but the exact activity could not be determined because of the 
insufficent solubility of the compounds in the buffer. Therefore, a more polar and better water 
soluble benzodiazepine derivative was synthesized and the biological activity was 
determined. The test results are inconsistent and therefore no final conclusion on its 
physiological effect can be derived.  
5.4 Experimental  
5.4.1 General Experimental Conditions 
The following compounds were prepared according to literature methods: 1,2-bis(5-chloro-2-
methylthiophen-3-yl)cyclopent-1-ene (9),14 5-chloro-2-methyl-3-(2-(2-methyl-5-phenyl-
thiophen-3-yl)cyclopent-1-en-1-yl)thiophene (10).15 All other reagents were obtained from 
commercial sources. Unless otherwise noted, solvents (analytical grade) were purchased 
from commercial suppliers and used without further purification. Melting points were obtained 
using a Lambda Photometrics Optimelt MPA100 apparatus (Lambda Photometrics, 
Harpenden, UK) and are not corrected. IR spectra were obtained using a Varian Biorad FT-
IR Excalibur FTS 3000 spectrometer. 1H NMR spectra were recorded at 300 MHz on a 
Bruker Avance 300 spectrometer, or at 600 MHz on a Bruker Avance III Br600 with a 
cryogenic probe head (Bruker, Karlsruhe, Germany). 13C NMR spectra were recorded at 75 
MHz on a Bruker Avance 300 spectrometer. The NMR spectra were recorded in CDCl3 as 
solvent and chemical shifts are reported in ppm. UV/Vis spectra were recorded using a 
Varian Cary BIO 50 UV/Vis/NIR spectrophotometer (Varian Inc., CA, USA). Mass spectra 
were obtained using Finnigan SSQ 710A (EI), Finnigan MAT 95 (CI) or Finnigan MAT TSQ 
7000 (Thermo  FINNIGAN, USA) (ES/LC– MS)] instrumentation. Thin layer chromatography 
(TLC) was performed on alumina plates coated with silica gel (Merck silica gel 60 F245, 
thickness 0.2 mm). Column chromatography was accomplished with Merck Geduran SI 60 
silica gel as the stationary phase. Petroleum ether (PE) refers to the fraction boiling at 30-60 
°C. 
5.4.2 Synthetic protocols and analytical data of compounds 2-4, 6-8, 12-14 and 16-21 
Photoswitchable benzodiazepine derivatives 2-4  
General procedure for the Suzuki coupling (GP 1)  
The DTE (1 eq) was dissolved in dry THF (3 mL) in a 10 mL capped vial under nitrogen 
atmosphere. After cooling to -80 °C, n-BuLi (2.0 M in hexane, 1.1 eq) was added dropwise 
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via a syringe and the resulting purple solution was stirred in the cold for 45 min. The reaction 
mixture was treated with trimethyl borate (1.5 eq) and the yellow solution was stirred at -80 
°C for 30 min, the cooling bath was then removed and it was stirred at r.t. for further 60 min. 
The reaction was quenched with aqueous Na2CO3 (2.0 M, 1 mL) and a solution of the 
appropriate BDA (1 eq) and Pd(dppf)Cl2 (0.03 eq) in THF (1 mL) was added to the reaction 
mixture. It was heated to 80 °C for 20 h by a heating block. After removal of the cap, the 
reaction mixture was diluted with EE (3 mL) and water (3 mL) and the phases were 
separated. The aqueous phase was extracted with EE (2 x 5 mL), the combined organic 
phases were dried over MgSO4 and the solvents were removed under reduced pressure. 
Purification of the crude product was performed by flash column chromatography. 
 
7-(4-(2-(5-Chloro-2-methylthiophen-3-yl)cyclopent-1-en-1-yl)-5-methylthiophen-2-yl)-5-
phenyl-1H-benzo[e][1,4]diazepin-2(3H)-one (2) 
Compound 2 was prepared from DTE 9 (56 mg, 0.17 mmol) and BDA 8 (62 mg, 0.17 mmol) 
following the general procedure GP 1 for Suzuki coupling. After flash column 
chromatography (PE/EE, 3:2 v/v), the compound was crystallized in EE and precipitated by 
the addition of hexane in the fridge. Finally, compound 2 was obtained as purple solid. Yield 
(420 mg, 66 %), mp 122-124 °C. 1H NMR (300 MHz, CDCl3): δ = 1.86 (s, 3H), 1.98 (s, 3H), 
1.99-2.07 (m, 2H), 2.70-2.80 (m, 4H), 4.35 (s, 2H), 6.56 (s, 1H), 6.86 (s, 1H), 7.13 (d, J = 8.5 
Hz, 1H), 7.36-7.49 (m, 4H), 7.56-7.62 (m, 3H), 8.94 (s, 1H) ppm; 13C NMR (75 MHz, CDCl3): 
14.2, 14.5, 22.9, 38.3, 38.3, 56.7, 76.6, 121.6, 124.5, 125.1, 126.8, 127.5, 128.3, 128.6, 
129.7, 130.0, 130.5, 133.2, 134.2, 135.0, 135.0, 135.3, 136.7, 137.4, 137.9, 139.11, 170.7, 
171.7 ppm; IR (film):
 
ν
 = 3270, 3056, 2950, 1680, 1635, 1590, 1565, 1500, 1440, 1380, 
1159, 1100, 1078, 960, 740, 510 cm-1; HRMS (ESI): calculated for C30H25ClN2OS2 528.1097; 
found 528.1043.
 
 
7-(5-Methyl-4-(2-(2-methyl-5-phenylthiophen-3-yl)cyclopent-1-en-1-yl)thiophen-2-yl)-5-
phenyl-1H-benzo[e][1,4]diazepin-2(3H)-one (3) 
Compound 4 was prepared from DTE 10 (56 mg, 0.15 mmol) and BDA 8 (54 mg, 0.15 mmol) 
following the general procedure for GP 1 for Suzuki coupling. After flash chromatography 
(PE/EE, 1:1 to 5:7 v/v), compound 3 was obtained as purple foam. Yield (79 mg, 92 %), mp 
92-93 °C. 1H NMR (300 MHz, CDCl3): δ = 1.96 (s, 3H), 2.00 (s, 3H), 2.03-2.11 (m, 2H), 2.79-
2.83 (m, 4H), 4.34 (s, 2H), 6.89 (s, 1H), 6.99 (s, 1H), 7.08 (d, J = 8.6 Hz, 1H), 7.28-7.41 (m, 
9H), 7.58 (dd, J = 2.1 Hz, 7.0 Hz, 2H), 7.62 (d, J = 2.1 Hz, 1H), 8.16 (s, 1H) ppm; 13C NMR 
(75 MHz, CDCl3): δ = 14.4, 14.5, 23.1, 38.4, 38.5, 58.9, 121.7, 123.9, 124.6, 125.3, 127.0, 
127.5, 128.6, 128.8, 129.7, 130.0, 130.5, 134.3, 134.4, 134.5, 135.1, 135.2, 136.5, 137.0, 
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137.5, 137.7 , 139.1, 139.8, 170.7, 171.9 ppm; IR (film): ν  = 1940, 1865, 1798, 1600, 1500, 
1400, 1350, 1250, 1160, 920, 720 cm-1; HRMS (ESI): calculated for C36H30N2OS2 570.1794; 
found 570.1790. 
 
8-(4-(2-(5-Chloro-2-methylthiophen-3-yl)cyclopent-1-en-1yl)-5-methylthiophen-2-yl)-5-
phenyl-1H-benzo[e][1,4]diazepin-2(3H)-one (4) 
Compound 4 was prepared from DTE 9 (50 mg, 0.15 mmol) and BDA 16 (54 mg, 0.15 mmol) 
following the general procedure GP 1 for Suzuki coupling.  A mixture of compound 4 and the 
dehalogenated product which could not be separated was obtained as a purple foam. Yield 
(356 mg, 45 %).  
 
(2-Amino-5-iodophenyl)(phenyl)methanone (6) 
2-Aminophenylmethanone 5 (1.18 g, 6 mmol), NaIO4 (1.51 g, 6 mmol), NaCl (0.70 g, 12 
mmol) and KI (1.00 g, 6 mmol) were dissolved in AcOH-water (500 mL, 9:1) and stirred for 
12 h at r.t. The compound was extracted with DCM (2 x 100 mL) and the organic layer was 
washed with water (2 x 100 mL) and conc. NaHSO3 (100 mL), dried over Na2SO4 and 
concentrated under reduced pressure. The crude product was purified by silica gel 
chromatography (PE/EE, 4:1 v/v) and a light red solid was obtained. Yield (1.15 g, 60 %). 
Analytical data are in accordance with literature reported values.16 
 
N-(2-Benzoyl-4-iodophenyl)-2-chloroacetamide (7) 
Under nitrogen atmosphere, 2-chloroacetyl chloride (0.24 mL, 3.0 mmol) was added to a 
solution of (2-amino-5-iodophenyl)(phenyl)methanone (1.00 g, 3.0 mmol) and Et3N (0.5 mL) 
in CHCl3 (10 mL) at 0 °C. The mixture was allowed to warm up and stirred at r.t. for 12 h. The 
organic layer was washed with distilled water (2 x 50 mL) and the water layer was extracted 
with CHCl3 (2 x 50 ml). The organic layers were combined, dried over Na2SO4 and filtered. 
The solvent was finally evaporated and the crude product was purified by column 
chromatography (PE/EE, 2:1 v/v) and a brown solid was obtained. Yield (0.9 g, 75 %), mp 
135-137 °C. 1H NMR (300 MHz, CDCl3): δ = 4.20 (s, 2H), 7.49-7.76 (m, 5H), 7.84-7.92 (m, 
2H), 8.45 (d, J = 8.5 Hz, 1 H), 11.48 (s, 1H) ppm; 13C NMR (75 MHz, CDCl3) : δ = 43.1, 86.1, 
123.5, 126.2, 128.6, 130.1, 133.20, 137.6, 138.8, 141.4, 142.5, 165.4, 197.7 ppm; IR (film): 
ν = 3273, 3056, 2956, 1682, 1635, 1592, 1570, 1507, 1444, 1386, 1290, 1252, 1159, 1119, 
1078, 967, 940, 888, 837, 801, 757, 740, 695, 649, 590, 516, 441 cm-1; HRMS (ESI): 
calculated for C15H11ClINO2 398.9523; found 398.9520. 
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7-Iodo-5-phenyl-1H-benzo[e][1,4]diazepin-2(3H)-one (8) 
To a solution of N-(2-benzoyl-5-iodophenyl)-2-chloroacetamide 7 (0.5 g, 1.3 mmol) in EtOH 
(30 mL), HMTM (387 mg, 2.8 mmol) and NH4(OAc) (216 mg, 2.8 mmol) were added and the 
reaction mixture was stirred under reflux for 12 h. The solvent was removed and the crude 
product was subjected to column chromatography (PE/EE, 2:1 v/v) and an orange solid was 
obtained. Yield (282 mg, 60 %). Analytical data are in accordance with literature reported 
values.16 
 
(2-Amino-4-iodophenyl)(phenyl)methanone (12) 
BCl3 (DCM 1 M, 13.07 mmol, 13.07 mL) was added to a solution of 3-iodoaniline (2.5 g, 11.4 
mmol) in 1,2-dichloroethane (9 mL) at 0 °C under nitrogen atmosphere. AlCl3 (1.68 g, 13.07 
mmol) and benzontitrile (1.16 mL, 11.4 mmol) were added to the reaction mixture and the 
solution was stirred under reflux at 80 °C for 20 h. After the reaction was completed, the 
reaction mixture was cooled to 0 °C and 2 M HCl (10 mL) was added. The mixture was 
stirred at 80 °C for 30 min and the product was extracted with DCM. The organic layer was 
washed with NaOH (1M) and brine, dried over MgSO4 and concentrated in vacuo. The 
compound was purified by flash column chromatography (PE/EE, 4:1 v/v) to give 2-amino-4-
iodophenyl)phenyl)methanone as a light red solid. Yield (553 mg, 15 %). Analytical data are  
in accordance to literature.17  
 
N-(2-Benzoyl-5-iodophenyl)-2-chloroacetamide (13) 
2-Chloroacetyl chloride (0.12 mL, 1.5 mmol) was added to a solution of (2-amino-5-
iodophenyl)(phenyl)methanone 12 (0.50 g, 1.5 mmol) and NEt3 (0.25 mL) in CHCl3 (10 mL) 
at 0 °C. The mixture was allowed to warm up and stirred at r.t. for 12 h. Distilled water (2 x 50 
mL) was added and the the organic phase was separated. The water phase was extracted 
with CHCl3 (2 x 10 ml) and the collected organic layers were combined, dried over Na2SO4, 
filtered and the solvent was removed in vacuo. The crude product was purified by flash 
chromatography (PE/EE, 2:1 v/v) and a yellow solid was obtained. Yield (470 mg, 70 %), mp 
130-132 °C. 1H NMR (300 MHz, CDCl3): δ = 4.20 (s, 2H), 7.49-7.76 (m, 5H), 7.84-7.92 (m, 
2H), 11.48 (s, 1H) ppm; 13C NMR (75 MHz, CDCl3): δ = 43.2, 86.2, 124.8, 126.2, 129.6, 
130.1, 133.4, 137.6, 138.8, 141.4, 142.2, 165.4, 197.7 ppm; IR (film) : ν = 3270, 3056, 2950, 
1680, 1635, 1590, 1565, 1500, 1440, 1380, 1159, 1100, 1078, 960, 740, 510 cm-1; HRMS 
(ESI): calculated for C15H11ClINO2 398.9523; found 398.9533.  
 
8-Iodo-5-phenyl-1H-benzo[e][1,4]diazepin-2(3H)-one (14)  
HMTM (310 mg, 2.2 mmol) and NH4(OAc) (216 mg, 2.8 mmol) were added to a solution of N-
(2-benzoyl-5-iodophenyl)-2-chloroacetamide (400 mg, 1.0 mmol) in EtOH (24 mL) and the 
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reaction mixture was stirred under reflux for 12 h. The solvent was removed in vacuo and the 
crude product was subjected to column chromatography (PE/EE = 2:1, v/v) and an orange 
solid was obtained. Yield (200 mg, 55 %), mp 140-142 °C. 1H NMR (300 MHz, CDCl3): δ = 
4.33 (s, 2H), 7.03 (d, J = 8.3 Hz, 2H), 7.34-7.57 (m, 6H), 9.15 s (1H) ppm; 13C NMR (75 MHz, 
CDCl3): δ = 43.1, 86.1, 123.5, 126.2, 128.6, 130.1, 133.2, 137.6, 138.8, 141.4, 142.6, 165.4, 
197.7 ppm; IR (film): ν = 3181, 3085, 2964, 2122, 2057, 1902, 1676, 1587, 1553, 1499, 
1476, 1444, 1376, 1321,1269, 1223, 1196, 1162, 1076, 1017, 951, 924, 870, 825, 776, 756, 
726, 695, 650, 583, 562, 546, 503, 458, 438 cm-1; HRMS (ESI): calculated for C15H11IN2O 
361.9916; found 361.9910.  
 
(2-Aminophenyl)(4-((trimethylsilyl)ethynyl)phenyl)methanone (16) 
Under nitrogen atmosphere, the solvent THF-NEt3 (48 mL, 2:1) was degassed for 15 min. 2-
Aminophenyl(4-bromophenyl)methanone (500 mg, 1.8 mmol), TMS-acetylene (0.51 mL, 3.6 
mmol), PdCl2(PPh3)2 (64 mg, 5 mol%), CuI (34 mg, 10 mol%) and PPh3 (48 mg, 10 mol%) 
were added and the solution was stirred under reflux for 12 h. Water (50 mL) was added and 
the organic layers were separated and extracted two times with Et2O (2 x 50 ml). The organic 
layers were combined, dried over MgSO4 and filtered. The solvent was evaporated and the 
product was purified by column chromatography (PE/EE = 2:1 v/v) and a black oil was 
obtained. Yield (500 mg, 95 %). 1H NMR (300 MHz, CDCl3): δ = 0.27 (s, 9H), 6.58-6.65 (m, 
1H), 6.70-6.78 (m, 1H), 7.27-7.34 (m, 1H), 7.37-7.41 (m, 1H), 7.52-7.60 (m, 4H) ppm; 13C 
NMR: δ = 0.0, 115.9, 117.3, 118.2, 126.1, 129.2, 131.7, 132.0, 134.4, 134.5, 134.5, 139.7, 
150.7, 198.3 ppm; IR (film): ν = 3200, 3040, 2950, 1670, 1630, 1590, 1570, 1500, 1442, 
1380, 1280, 1070, 725, 580 cm-1; HRMS (ESI): calculated for C18H19NOSi 293.1253; found 
293.1250.  
 
(2-Amino-5-iodophenyl)(4-ethynylphenyl)methanone (17) 
(2-Amino-5-iodophenyl((4-((trimethylsilyl)ethynyl)phenyl)methanone 16 (800 mg, 2.8 mmol), 
NaIO4 (584 mg, 2.8 mmol), KI (456 mg, 2.8 mmol) and NaCl (160 mg, 2.8 mmol) were 
dissolved in a solution of AcOH-water (320 mL, 9:1) and stirred over night at r.t. for 24 h. The 
compound was extracted with DCM (3 x 100 mL), the organic layer was washed with 1 M 
NaOH (200 ml) and separated, dried over MgSO4, filtered and evaporated. The crude 
product was dissolved in MeOH (50 mL), K2CO3 (3.5 g, 25.4 mmol) was added and the 
mixture was stirred overnight at r.t. DCM (200 mL) and water (200 ml) were added and the 
organic layer was separated, dried over MgSO4, filtered and evaporated. The crude product 
was purified by column chromatography (PE/EE = 2:1 v/v) and an orange solid was obtained. 
Yield (480 mg, 70 %). 1H NMR (300 MHz, CDCl3): δ = 3.23 (s, 1H), 6.57 (d, J = 8.7 Hz, 1H), 
7.46-7.67 (m, 6H) ppm; 13C NMR (75 Mhz): δ = 80.9, 82.5, 86.1, 123.6, 125.9, 127.1, 129.9, 
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132.7, 137.4, 138.8, 141.3, 142.9, 196.8 ppm; HRMS (ESI): calculated for C15H10INO 
346.9807; found 346.9800.  
 
2-Chloro-N-(2-(4-ethynylbenzoyl)-4-iodophenyl)acetamide (18) 
Under nitrogen atmosphere, (2-aminophenyl)(4-((trimethylsilyl)ethynyl)phenyl)methanone 17 
(400 mg, 1.2 mmol) and Et3N (0.11 ml) were dissolved in CHCl3 (15 mL) and chloroacetyl 
chloride (0.11 mL, 1.3 mmol) was added dropwise to the solution at 0 °C. The solution was 
allowed to warm up and stirred at r.t. for 12 h. Water (20 mL) was added to the solution and 
the organic layer was separated. The water layer was extracted with DCM (2 x 20 mL) and 
the organic layers were combined, dried over MgSO4, filtered and the solvent was 
evaporated to dryness. The product was purified by silica gel flash chromatography (PE/EE, 
2:1 v/v) and a brown solid was obtained. Yield (355 mg, 70%), mp 160-162 °C. 1H NMR (300 
MHz, CDCl3): δ = 3.29-3.30 (s, 1H), 4.19 (s, 2H), 7.57-7.71 (m, 4H), 7.82-7.84 (m, 1H), 7.86-
7.91 (m, 1H), 8.39-8.43 (m, 1H), 11.43 (s, 1H) ppm; 13C NMR (75 MHz, CDCl3): δ = 43.1, 
80.9, 82.5, 86.1, 123.6, 125.9, 127.1, 129.9, 132.3, 137.4, 138.8, 141.3, 142.9, 165.4, 196.8 
ppm; IR (film): ν = 487, 521, 562, 599, 645, 665, 724, 780, 845, 900, 932, 964, 1015, 1082, 
1111, 1155, 1175, 1235, 1250, 1289, 1309, 1384, 1403, 1508, 1567, 1590, 1633, 1689, 
1946, 1990, 2026, 2111, 2168, 2952, 3116, 3289 cm-1; HRMS (ESI): calculated for 
C17H11ClINO2 422.9523; found 422.9520.  
 
5-(4-Ethynylphenyl)-7-iodo-1H-benzo[e][1,4]diazepin-2(3H)-one (19) 
Under nitrogen atmosphere, 2-chloro-N-(2-(4-ethynylbenzoyl)-4-iodophenyl)acetamide 18 
(320 mg, 0.8 mmol), NH4(OAc) (128 mg, 1.7 mmol) and HMTM (233 mg, 1.7 mmol) were 
dissolved in EtOH (100 mL) and stirred under reflux for 48 h. The solvent was evaporated to 
dryness and the precipitate was taken up in DCM (50 mL). The organic layer was washed 
with water (50 mL), dried over MgSO4, filtered and evaporated to dryness. The product was 
purified by column chromatography (PE/EE, 2:1 v/v) and a brown solid was obtained. Yield: 
(154 mg, 50 %). 1H NMR (300 MHz, CDCl3): δ = 3.21 (s, 1H), 4.32 (s, 2H), 6.94 (d, J = 8.5 
Hz, 1H), 7.49-7.56 (m, 4H), 7.58-7.61 (d, J = 7.6 Hz, 1H), 7.80 (dd, J = 10.5 , 8.5 Hz, 1H), 9.0 
(s, 1H) ppm; 13C NMR (75 MHz, CDCl3): δ = 56.7, 81.5, 82.4, 119.8, 125.0, 127.6, 128.8, 
131.7, 131.7, 132.0, 132.5, 138.4, 138.8, 168.6, 170.2 ppm; IR (film):
 
ν
 = 3262, 3100, 2924, 
2854, 2364, 2200, 2169, 1979, 1950, 1681, 1596, 1560, 1474, 1381, 1312, 1284, 1264, 
1227, 1109 cm-1; HRMS (ESI): calculated for C17H11IN2O 385.9916; found 385.9920. 
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5-(4-(1-(2-(2-(2-Hydroxyethoxy)ethoxy)ethyl)-1H-1,2,3-triazol-4-yl)phenyl)-7-iodo-1H-
benzo[e][1,4]diazepin-2(3H)-one (20) 
Under nitrogen atmosphere 5-(4-ethynylphenyl)-7-iodo-1H-benzo[e][1,4]diazepin-2(3H)-one 
19 (100 mg, 0.26 mmol), 2-(2-(2-azidoethoxy)ethoxy)ethanol (59 mg, 0.34 mmol), Cu(SO4) x 
5 H2O (32 mg, 0.13 mmol) and sodium ascorbate (128 mg, 0.64 mmol) were dissolved in 
DMF (10 mL) and stirred for 24 h at r.t. EE (100 mL) was added and the organic layer was 
washed with brine (5 x 100 mL). The organic layers were combined, dried over MgSO4, 
filtered and the solvent was removed in vacuo. The product was purified by flash column 
chromatography (EtOH) and a colorless oil was obtained. Yield: (63 mg, 57 %). 1H NMR (300 
MHz, CDCl3): δ = 3.55-3.60 (m, 2H), 3.63-3.64 (m, 4H), 3.69-3.74 (m, 2H), 3.90-3.94 (m, 2H), 
4.33 (s, 2H), 4.60 (t, J = 4.8, 9.8 Hz, 2H), 5.30 (s, 1H), 6.95 (d, J = 8.5 Hz, 1H), 7.54-7.60 (m, 
2H), 7.65 (d, J = 1.98 Hz, 1H), 7.76 (dd, J = 2.0, 8.5 Hz, 1H), 7.84-7.90 (m, 2H), 8.05 (s, 1H), 
9.20 (s, 1H) ppm; 13C NMR (75 MHz, CDCl3): δ = 50.4, 61.7, 69.5, 70.2, 70.6, 72.5, 86.8, 
121.7, 123.1, 125.6, 129.1, 130.2, 133.0, 138.2, 138.4, 139.7, 140.5, 146.7, 159.9, 169.2, 
171.5 ppm; IR (film): ν = 3201, 3099, 2920, 2850, 2360, 1890, 1680, 1320, 1227, 1108, 830, 
560, 470 cm-1; HRMS (ESI): calculated for C23H24IN5O4 561.0873; found 561.0870.  
 
7-(4-(2-(5-Chloro-2-methylthiophen-3-yl)cyclopent-1-en-1-yl)-5-methylthiophen-2-yl)-5-
(4-(1-(2-(2-(2-hydroxyethoxy)ethoxy)ethyl)-1H-1,2,3-triazol-4-yl)phenyl)-1H-
benzo[e][1,4]diazepin-2(3H)-one (21) 
DTE 10 (36 mg, 0.11 mmol) was dissolved in dry THF (20 mL) under nitrogen atmosphere 
and cooled to -70 °C by a bath of dry ice in EtOH. n-BuLi (1.32 M in hexane, 91 µL, 
0.12 mmol) was added dropwise via syringe and the resulting purple solution was stirred in 
the cold for 60 min and then it was treated with trimethyl borate (18 µL, 0.16 mmol). It was 
stirred for 30 min at -70 °C and after removal of the dry ice bath for further 60 min at r.t. The 
reaction was then quenched with aqueous Na2CO3 (2 M, 10 mL). After adding the BDA 20 
(61 mg, 0.11 mmol), the reaction mixture was degassed by nitrogen bubbling for 15 min. 
Pd(PPh3)2Cl2 (4 mg, 0.005 mmol) was added and the reaction was heated to 80 °C over- 
night. After cooling to r. t., the reaction mixture was diluted with DCM and water and the 
phases were separated. The aqueous phase was extracted with DCM (2 x 5 mL), the 
combined organic phases were dried over MgSO4 and the solvents removed under reduced 
pressure. Purification of the crude product was performed by automated flash column 
chromatography (EtOH/DCM 9.8:0.2,  9:1 v/v)  followed by automated RP flash column 
chromatography (MeCN/water 0-100%) yielding compound 21 as purple oil. Yield: (53 mg, 
66 %). 1H NMR (300 MHz, CDCl3): δ = 1.85 (s, 3), 1.95 (s, 3H), 2.00 (t, J = 7.3 Hz, 2H), 2.73 
(dt, J = 7.3, 7.4 Hz, 4H), 3.45-3.78 (m, 8H), 3.92 (t, J = 4.9 Hz, 2H), 4.36 (s, 2H), 4.60 (t, J = 
4.9 Hz, 2H), 6.55 (s, 1H), 6.86 (s, 1H), 7.15 (d, J = 8.5 Hz), 7.41 (d, J = 2.0 Hz, 1H), 7.52-
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7.73 (m, 3H), 7.87 (d, J = 8.4 Hz, 2H), 8.04 (s, 1H), 9.06 (s, 1H) ppm; 13C NMR (75 Mhz, 
CDCl3): δ = 14.2, 14.4, 22.9, 28.3, 38.4, 50.4, 56.8, 61.7, 69.5, 70.3, 70.7, 72.5, 121.6, 121.7, 
124.4, 125.0, 125.5, 126.8, 127.4, 128.7, 130.0, 130.3, 132.8, 133.2, 134.2, 135.0, 135.3, 
136.7, 137.4, 137.8, 138.6, 147.0, 170.2, 171.6 ppm; HRMS (ESI): calculated for 
C38H38ClN5O4S2 728.2127; found 728.2125.  
5.4.3 Biology - Methods of the Working Group of Prof. Bregestovski 
Cell culture, transient transfection and electrophysiological recording was done as reported in 
literature.18 
5.4.4 Biology - Methods of the Group of Prof. Sigel 
Xenopus surgery, expression of GABAA-Receptors in Xenopus Oocytes, functional 
characterization of the GABAA-Receptors was done as reported in literature.8, 19, 20 
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Appendix 
 
 
 
A1. Abbreviations 
abs.  absolute  
ATP  adenosintriphosphate 
BAPTA 1,2-bis(o-aminophenoxy)ethane-N,N,N´,N´-tetraacetic acid 
BDA  benzodiazepine 
Bn  benzyl 
Boc  tert-butoxycarbonyl 
cDNA  complementary desoxyribonucleic acid 
CHO  chinese hamster ovary 
CNS  central nervous system 
conc.  concentrated 
cRNA  complementary ribonucleic acid 
d  day 
dppp  1,3-bis(diphenylphosphino)propan 
dppe  1,2-bis(diphenylphosphino)ethane 
dppf  1,1-bis(diphenylphosphino)ferrocen 
DCM  dichloromethane 
DMF  dimethylformamide 
DMSO  dimethyl sulfoxide 
DTE  dithienylethene 
EC50  agonist concentration that elicts 50 % of the max. response 
EE  ethyl acetate 
EI  electron ionization 
eq  equivalent 
ESI  electron spray ionization 
Et3N  triethylamine 
EtOH  ethanol 
eV  electron volt 
GABA  gamma amino butyric acid 
GC  gas chromatography 
GP  general procedure 
GTP  guanosine triphosphate 
Appendix 
67 
h  hour 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HMTM  hexamethylenetetramine 
HPLC  high performance liquid chromatography 
HRMS  high resolution mass spectroscopy 
IR  infrared spectroscopy 
LC  liquid chromatography 
MeOH  methanol 
MHz  megahertz 
MOHm mega ohm 
mp  melting point 
MS  mass spectroscopy 
n  number 
NIR  near infrared spectroscopy 
NMR  nuclear magnetic resonance 
ORTEP oak ridge thermal ellipsoid plot 
Osm  osmole 
pCMV  porcine cytomegalovirus 
PE  petrolether 
PEG  polyetheylene glycol 
Pin  pinacole 
ppm  parts per million 
r.t.  room temperature 
Rf  retention factor 
RP  reverse phase 
SI  supporting information 
t1/2  half-life time 
TEA  triethanolamine 
temp.  temperature 
THF  tetrahydrofurane 
TLC  thin layer chromatography 
UV  ultraviolet 
VIS  visible 
wt  weight percent 
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A3. Summary in German and English 
Summary in German 
Kapitel 1 beschreibt die Synthese von symmetrischen und unsymmetrischen 
Diarylcyclobutenen in einer Kobalt-katalysierten [2+2] Cycloadditionsreaktion. Dazu wurden 
die entsprechenden Diarylalkinvorstufen mit Cyclopenten oder einem Norbornenderivat 
umgesetzt. Die Reaktion läuft unter milden Reaktionsbedingungen bei Raumtemperatur ab 
und die gewünschten Produkte konnten in 20-70 % Ausbeute isoliert werden. Die 
erhaltenen Diarylcyclobutene sind reversibel photoschaltbar und die geschlossenen 
Isomere zeigten Halbwertszeiten von 9 – 300 h. 
 
Kapitel 2 behandelt die Synthese von photoschaltbaren Diarylcyclohexenen in einer Kobalt-
katalysierten Diels-Alder Cycloadditionsreaktion. Dazu wurden verschiedene Diaryl-
acetylene mit Boropren umgesetzt und eine dihydroaromatische Zwischenstufe mit einer 
Allylboronsäuregruppe generiert. Diese Zwischenstufe wurde dann in situ mit 
verschiedenen Aldehyden umgesetzt und photochrome Diarylcyclohexene erhalten. Die 
Synthesemethode ermöglicht die einfache Einführung von funktionellen Gruppen am 
Rückgrat des Photoschalters ohne den Chromophor zu beeinflussen. Eine Anwendung für 
die funktionalisierten Diarylethene wird durch die Immobilisierung der Farbstoffe auf 
Cellulose und Silikagel gezeigt.  
 
Kapitel 3 beschreibt die Synthese, Reinigung und biologische Testung von neuen und 
zuvor literaturbekannten GABA-Amiden und die Bestimmung des Effekts auf die 
Aktivierung von GABAA-Rezeptoren durch Patchclamp-Messungen in CHO-Zellen 
exprimierten GABAA-Rezeptoren. Um Verfälschungen der Messungen durch GABA-
Verunreinigung, die in der Synthese entstehen können, ausschließen zu können, wurde 
eine verbesserte Reinigungsmethode und HPLC-MS Bestimmungsmethode entwickelt. Wir 
konnten die in der Literatur beschriebenen Ergebnisse nicht bestätigen, aber die neu 
synthetisierten GABA-Amide zeigten moderate Aktivierung des GABAA-Rezeptors und es 
war uns möglich eine eindeutige Struktur-Wirkungsbeziehung abzuleiten.  
 
Kapitel 4 behandelt die Synthese von photoschaltbaren Liganden mit potentiellem Effekt 
auf die Aktivierung des GABAA-Kanals. Dazu wurden in einer ersten Testreihe drei mit 
einem Diarylethenphotoschalter substituierte Benzodiazepinderivate synthetisiert und deren 
Effekt auf die Aktivierung des GABAA-Kanals von zwei unabhängigen Forschungsgruppen 
durch Patch-Clamp Messungen an GABAA-Rezeptoren untersucht. Zwei der synthetisierten 
Benzodiazepinderivate aus der ersten Serie zeigten moderate Verstärkung der durch 
GABA verursachten Signale, die genaue Aktivität konnte jedoch nicht bestimmt werden, da 
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die Substanzen eine zu geringe Wasserlöslichkeit hatten. Durchgeführte 
Bestrahlungsexperimente mit UV-Licht gaben auch kein eindeutiges Ergebnis und waren 
nicht reproduzierbar. Deshalb wurde ein besser wasserlösliches Benzodiazepin-Derivat 
synthetisiert und der Effekt auf den GABAA-Rezeptor bestimmt. Die Meßergebnisse waren 
jedoch widersprüchlich und bis zum jetzigen Zeitpunkt kann keine eindeutige 
wissenschaftliche Aussage gemacht werden.  
 
Summary in English  
Chapter 1 describes the synthesis of symmetric and unsymmetric diarylcyclobutenes in a 
cobalt-catalyzed [2+2] cycloaddition reaction. Therefore, the appropriate diarylalkyne 
precursors were reacted with cyclopentene or a norbornene derivative. The reaction 
proceeds under mild reaction conditions at room temperature and the target compounds 
could be obtained in 20-70 % yield. The synthesized diarylcyclobutenes are reversibly 
photoswitchable and show different thermal stability towards reisomerization with half-lives 
ranging from 9 – 300 h.  
 
Chapter 2 deals with the synthesis of photoswitchable diarylcyclohexenes in a cobalt 
catalyzed Diels-Alder cycloadditon reaction. Therefore different diarylacetylenes were 
reacted with boroprene and a dihydroaromatic intermediate with an allylboronic ester 
subunit was generated and then reacted in sito with different aldehydes and photochromic 
diarycyclohexenes were obtained. The synthesis allows the simple introduction of functional 
groups at the backbone of the photoswitch without affecting the chromophore. An 
application of the functionalized diarylethenes is the immobilization of the chromophore on 
cellulose and silica gel.   
 
Chapter 3 describes the synthesis and purification of new and literature reported GABA-
amides and the determination of their effect with patch-clamp recording on GABAA-
receptors which were expressed in CHO-cells. In order to exclude contaminations of GABA 
which could falsify test results, an improved purification method and sensitive HPLC-MS 
analysis was developed. We could not confirm the literature reported results, but the new 
GABA-amides showed moderate activation of the GABAA-receptor and we were able to 
predict a clear structure activity relationship.  
 
Chapter 4 describes the synthesis of photoswitchable ligands with potential effect on the 
activation of the GABAA-receptor. Therefore, in a first approach, a series of benzodiazepine 
derivatives substituted with a diarylethene photoswitch were synthesized and their effect on 
GABAA-receptor activation was determined by two independent research groups with patch 
Appendix 
71 
clamp recording. Two of the compounds out of the first series showed moderate 
amplification of GABA induced current, but the exact activity could not be determined 
because of the insufficient solubility of the compounds in aqueous solution. UV-irradiation 
experiments gave no clear results and were not reproducible. Therefore, a better water 
soluble benzodiazepine derivative was synthesized and the effect of GABAA-receptor 
activation was determined. The test results were inconsistent and until now, no definite 
scientific conclusion can be drawn.  
 
